UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark one)


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September 30, 2021~~March 31, 2022

Or

☐	TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	or
For the transition period from _________ to _________

Commission file number: 000-33123

China Automotive Systems, Inc.

(Exact name of registrant as specified in its charter)


Delaware		33-0885775
(State or other jurisdiction of incorporation or		(I.R.S. Employer Identification No.)
organization)

No. 1 Henglong Road, Yu Qiao Development Zone, Shashi District

Jing Zhou City, Hubei Province, the People’s Republic of China

(Address of principal executive offices)

(86) 716- 412- 7901

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading symbol	Name of each exchange on which registered
Common Stock, $0.0001 par value	CAAS	The Nasdaq Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

~~Securities registered pursuant to Section 12(b) of the Act:~~


~~Title of each class~~	~~Trading symbol~~	~~Name of each exchange on which registered~~
~~Common Stock, $0.0001 par value~~	~~CAAS~~	~~The Nasdaq Capital Market~~

As of ~~November 12, 2021,~~May 23, 2022, the Company had 30,851,776 shares of common stock issued and outstanding.

Table of Contents

CHINA AUTOMOTIVE SYSTEMS, INC.

INDEX


		Page

	Part I — Financial Information	4

Item 1.	Unaudited Financial Statements.	4
	Condensed Unaudited Consolidated Statements of Operations and Comprehensive Income for the Three Months Ended March 31, 2022 and ~~Nine Months Ended September 30,~~ 2021 ~~and 2020~~	4
	Condensed Unaudited Consolidated Balance Sheets as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021	65
	Condensed Unaudited Consolidated Statements of Cash Flows for the ~~Nine~~Three Months Ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~	76
	Notes to Condensed Unaudited Consolidated Financial Statements	87
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	2421
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	3932
Item 4.	Controls and Procedures.	3932

	Part II — Other Information	4033

Item 1.	Legal Proceedings.	4033
Item 1A.	Risk Factors.	4033
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	4233
Item 3.	Defaults Upon Senior Securities.	4233
Item 4.	Mine Safety Disclosures.	4233
Item 5.	Other Information.	4233
Item 6.	Exhibits.	4334

Signatures		4435

Table of Contents

Cautionary Statement

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These statements relate to future events or the Company’s future financial performance. The Company has attempted to identify forward-looking statements by terminology including “anticipates,” “believes,” “expects,” “can,” “continues,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “should” or “will” or the negative of these terms or other comparable terminology. Such statements are subject to certain risks and uncertainties, including the matters set forth in this Quarterly Report or other reports or documents the Company files with the Securities and Exchange Commission from time to time, which could cause actual results or outcomes to differ materially from those projected. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance or achievements. Undue reliance should not be placed on these forward-looking statements, which speak only as of the date hereof. The Company’s expectations are as of the date this Form 10-Q is filed, and the Company does not intend to update any of the forward-looking statements after the date this Quarterly Report on Form 10-Q is filed to conform these statements to actual results, unless required by law. All of the forward-looking statements are qualified in their entirety by reference to the factors discussed under Item 1A. “Risk Factors” in ~~this Quarterly Report on Form 10-Q and~~ the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2020~~2021, as filed with the Securities and Exchange Commission.

Table of Contents

PART I — FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS.

China Automotive Systems, Inc. and Subsidiaries

Condensed Unaudited Consolidated Statements of Operations and Comprehensive Income

(In thousands of USD, except share and per share amounts)

Three Months Ended September 30,

2021

2020
Net product sales ($14,691 and $16,840 sold to related parties for the three months ended September 30, 2021 and 2020)

$
108,231

$
114,417
Cost of products sold ($6,505 and $7,012 purchased from related parties for the three months ended September 30, 2021 and 2020)

91,439

100,842
Gross profit

16,792

13,575
Gain on other sales

487

1,497
Less: Operating expenses

Selling expenses

4,802

3,800
General and administrative expenses

6,174

5,142
Research and development expenses

5,712

6,072
Total operating expenses

16,688

15,014
Income from operations

591

58
Other income

2,407

350
Interest expense

(255)

(403)
Financial expense, net

(821)

(2,313)
Income/(loss) before income tax expenses and equity in earnings of affiliated companies

1,922

(2,308)
Less: Income taxes expense/(benefit)

2,441

(189)
Add: Equity in earnings of affiliated companies

251

3,632
Net (loss)/income

(268)

1,513
Less: Net income/(loss) attributable to non-controlling interests

42

(848)
Accretion to redemption value of redeemable non-controlling interests

(7)

(3)
Net (loss)/income attributable to parent company’s common shareholders

$
(317)

$
2,358
Comprehensive income:

Net (loss)/income

$
(268)

$
1,513
Other comprehensive income:

Foreign currency translation (loss)/income, net of tax

(1,338)

12,774
Comprehensive (loss)/income

(1,606)

14,287
Comprehensive (loss)/income attributable to non-controlling interests

(40)

77
Accretion to redemption value of redeemable non-controlling interests

(7)

(3)
Comprehensive (loss)/income attributable to parent company

$
(1,573)

$
14,207

Net (loss)/income attributable to parent company’s common shareholders per share -

Basic

$
(0.01)

$
0.08
Diluted

$
(0.01)

$
0.08

Weighted average number of common shares outstanding -

Basic

30,851,776

31,112,076
Diluted

30,851,776

31,113,374

~~The accompanying notes are an integral part of these condensed unaudited consolidated financial statements.~~

~~Table of Contents~~

~~China Automotive Systems, Inc. and Subsidiaries~~

~~Condensed Unaudited Consolidated Statements of Operations and Comprehensive Income~~

~~(In thousands of USD, except share and per share amounts)~~


	Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2022		2021
Net product sales ($47,016 and $40,439 sold to related parties for the nine months ended September 30, 2021 and 2020)	$	359,176	$	271,156
Cost of products sold ($21,916 and $16,298 purchased from related parties for the nine months ended September 30, 2021 and 2020)		306,807		238,598
Net product sales ($11,004 and $16,575 sold to related parties for the three months ended March 31, 2022 and 2021)					$	136,396	$	130,341
Cost of products sold ($7,540 and $8,214 purchased from related parties for the three months ended March 31, 2022 and 2021)						121,662		110,593
Gross profit		52,369		32,558		14,734		19,748
Gain on other sales		2,528		2,935		931		1,316
Less: Operating expenses
Selling expenses		14,857		8,895		4,312		5,609
General and administrative expenses		16,852		13,330		4,754		4,615
Research and development expenses		18,318		17,390		8,137		6,680
Total operating expenses		50,027		39,615		17,203		16,904
Income/(loss) from operations		4,870		(4,122)
(Loss)/income from operations						(1,538)		4,160
Other income, net		5,636		1,724		3,519		1,723
Interest expense		(892)		(1,214)		(402)		(343)
Financial expense, net		(878)		(2,903)
Income/(loss) before income tax expenses and equity in earnings of affiliated companies		8,736		(6,515)
Less: Income taxes expense		3,280		294
Add: Equity in earnings of affiliated companies		435		3,454
Net income/(loss)		5,891		(3,355)
Less: Net loss attributable to non-controlling interests		(219)		(1,590)
Financial income/(expense), net						2,015		(239)
Income before income tax expenses and equity in earnings of affiliated companies						3,594		5,301
Less: Income taxes						958		641
Add: Equity in loss of affiliated companies						(2,487)		(1,429)
Net income						149		3,231
Less: Net income attributable to non-controlling interests						200		18
Accretion to redemption value of redeemable non-controlling interests		(21)		(3)		(8)		(7)
Net income/(loss) attributable to parent company’s common shareholders	$	6,089	$	(1,768)
Net (loss)/income attributable to parent company’s common shareholders					$	(59)	$	3,206
Comprehensive income:
Net income/(loss)	$	5,891	$	(3,355)
Net income					$	149	$	3,231
Other comprehensive income:
Foreign currency translation income, net of tax		1,977		8,171
Foreign currency translation income/(loss), net of tax						1,437		(2,271)
Comprehensive income		7,868		4,816		1,586		960
Comprehensive loss attributable to non-controlling interests		(92)		(1,062)
Comprehensive income/(loss) attributable to non-controlling interests						289		(118)
Accretion to redemption value of redeemable non-controlling interests		(21)		(3)		(8)		(7)
Comprehensive income attributable to parent company	$	7,939	$	5,875	$	1,289	$	1,071

Net income/(loss) attributable to parent company’s common shareholders per share -
Net (loss)/income attributable to parent company’s common shareholders per share -
Basic	$	0.20	$	(0.06)	$	(0.00)	$	0.10
Diluted	$	0.20	$	(0.06)	$	(0.00)	$	0.10

Weighted average number of common shares outstanding -
Basic		30,851,776		31,153,162		30,851,776		30,851,776
Diluted		30,855,967		31,153,162		30,851,776		30,857,736

Share-based compensation included in operating expense above is as follows:
General and administrative expenses		88		0		0		88

The accompanying notes are an integral part of these condensed unaudited consolidated financial statements.

Table of Contents

China Automotive Systems, Inc. and Subsidiaries

Condensed Unaudited Consolidated Balance Sheets

(In thousands of USD unless otherwise indicated)


	September 30, 2021		December 31, 2020		March 31, 2022		December 31, 2021
ASSETS
Current assets:
Cash and cash equivalents	$	80,729	$	97,248	$	79,402	$	131,695
Pledged cash		34,272		30,813		30,047		27,804
Accounts and notes receivable, net - unrelated parties		200,221		216,519		211,035		195,729
Accounts and notes receivable - related parties		27,055		17,621
Accounts and notes receivable, net - related parties						11,362		14,607
Inventories		106,427		88,325		114,483		116,493
Other current assets		28,762		25,132		59,252		15,052
Total current assets		477,466		475,658		505,581		501,380
Non-current assets:
Property, plant and equipment, net		129,249		141,004		123,436		127,721
Land use rights, net		10,623		10,774		10,705		10,732
Long-term investments		40,742		49,766		60,660		36,966
Other non-current assets		28,066		30,358		26,265		39,963
Total assets	$	686,146	$	707,560	$	726,647	$	716,762

LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY
Current liabilities:
Short-term loans	$	42,210	$	44,238	$	48,185	$	47,592
Accounts and notes payable - unrelated parties		203,132		212,522
Accounts and notes payable - related parties		11,975		12,730
Accounts and notes payable-unrelated parties						215,892		214,590
Accounts and notes payable-related parties						11,784		13,464
Accrued expenses and other payables		52,293		55,607		58,340		50,332
Other current liabilities		22,228		29,387		25,819		25,838
Total current liabilities		331,838		354,484		360,020		351,816
Long-term liabilities:
Other long-term payable		—		1,126
Long-term tax payable		21,074		23,884		21,075		21,075
Other non-current liabilities		6,437		8,151		6,525		6,430
Total liabilities	$	359,349	$	387,645	$	387,620	$	379,321

Commitments and Contingencies (See Note 23)
Commitments and Contingencies (See Note 22)

Mezzanine equity:
Redeemable non-controlling interests		544		523		561		553

Stockholders’ equity:
Common stock, $0.0001 par value - Authorized - 80,000,000 shares; Issued –32,338,302 and 32,338,302 shares as of September 30, 2021 and December 31, 2020, respectively	$	3	$	3
Common stock, $0.0001 par value - Authorized - 80,000,000 shares; Issued – 32,338,302 and 32,338,302 shares as of March 31, 2022 and December 31, 2021, respectively					$	3	$	3
Additional paid-in capital		63,731		64,273		63,731		63,731
Retained earnings-
Appropriated		11,303		11,303		11,481		11,481
Unappropriated		221,580		215,491		226,304		226,363
Accumulated other comprehensive income		19,263		17,413		26,065		24,717
Treasury stock –1,486,526 and 1,486,526 shares as of September 30, 2021 and December 31, 2020, respectively		(5,261)		(5,261)
Total parent company stockholders' equity		310,619		303,222
Treasury stock – 1,486,526 and 1,486,526 shares as of March 31, 2022 and December 31, 2021, respectively						(5,261)		(5,261)
Total parent company stockholders’ equity						322,323		321,034
Non-controlling interests		15,634		16,170		16,143		15,854
Total stockholders' equity		326,253		319,392
Total liabilities, mezzanine equity and stockholders' equity	$	686,146	$	707,560
Total stockholders’ equity						338,466		336,888
Total liabilities, mezzanine equity and stockholders’ equity					$	726,647	$	716,762

The accompanying notes are an integral part of these condensed unaudited consolidated financial statements.

Table of Contents

China Automotive Systems, Inc. and Subsidiaries

Condensed Unaudited Consolidated Statements of Cash Flows

(In thousands of USD unless otherwise indicated)


	Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2022		2021
Cash flows from operating activities:
Net income/(loss)	$	5,891	$	(3,355)
Adjustments to reconcile net income/(loss)from operations to net cash (used in)/provided by operating activities:
Net income					$	149	$	3,231
Adjustments to reconcile net income from operations to net cash provided by /(used in) operating activities:
Share-based compensation		88		0		0		88
Depreciation and amortization		19,686		15,935		6,207		6,544
Provision/(reversal) of credit losses		1,644		(360)		100		(177)
Deferred income taxes		2,573		464		286		(254)
Equity in gain of affiliated companies		(435)		(3,454)
Government subsidy reclassified from government loans		0		287
Equity in loss of affiliated companies						2,487		1,429
Loss on fixed assets disposals		71		67		37		9
(Increase)/decrease in:
Accounts and notes receivable		6,631		29,454		(11,184)		(3,972)
Inventories		(17,500)		2,644		2,532		(1,934)
Other current assets		(129)		1,214		(1,281)		(1,371)
Increase/(decrease) in:
Accounts and notes payable		(11,506)		10,493		(1,407)		1,595
Accrued expenses and other payables		(2,325)		2,451		(2,041)		(4,135)
Long-term taxes payable		(2,809)		(2,809)
Other current liabilities		(7,462)		(289)		(135)		(1,811)
Other non-current liabilities		(285)		0
Net cash (used in)/provided by operating activities		(5,867)		52,742
Net cash used in operating activities						(4,250)		(758)
Cash flows from investing activities:
(Decrease)/Increase in demand loans included in other non-current assets		(357)		44
Decrease/(increase) in demand loans included in other non-current assets						242		(33)
Repayment of loan from a related party		154		0		0		154
Cash received from property, plant and equipment sales		252		1,444		95		51
Payments to acquire property, plant and equipment (including $929 and $1,677 paid to related parties for the nine months ended September 30, 2021 and 2020, respectively)		(5,344)		(8,879)
Payments to acquire property, plant and equipment (including $794 and $137 paid to related parties for the three months ended March 31, 2022 and 2021, respectively)						(1,024)		(3,267)
Payments to acquire intangible assets		(505)		(422)		(40)		(112)
Investment under the equity method		(308)		(5,360)		(4,724)		—
Purchase of short-term investments and long-term time deposits		(46,212)		(42,716)
Purchase of short-term investments						(44,693)		(14,661)
Proceeds from maturities of short-term investments		40,016		21,626		1,801		9,873
Cash received from long-term investment		10,116		448		2,704		2,237
Net cash used in investing activities		(2,188)		(33,815)		(45,639)		(5,758)
Cash flows from financing activities:
Proceeds from bank loans		42,700		39,586		16,088		12,569
Repayments of bank loans		(44,854)		(50,550)		(15,701)		(10,086)
Repayments of the borrowing for sale and leaseback transaction		(3,328)		(3,078)		(1,130)		(1,107)
Cash received from capital contributions by non-controlling interest holder		0		722
Deemed distribution to shareholders		0		(88)
Acquisition of non-controlling interest		(538)		(81)
Repurchase of common shares		0		(1,000)
Net cash used in financing activities		(6,020)		(14,489)
Net cash (used in)/provided by financing activities						(743)		1,376
Effects of exchange rate on cash, cash equivalents and pledged cash		1,015		2,647		583		(884)
Net (decrease)/increase in cash, cash equivalents and pledged cash		(13,060)		7,085
Net decrease in cash, cash equivalents and pledged cash						(50,049)		(6,024)
Cash, cash equivalents and pledged cash at beginning of the period		128,061		106,403		159,498		128,061
Cash, cash equivalents and pledged cash at end of the period	$	115,001	$	113,488	$	109,449	$	122,037

The accompanying notes are an integral part of these condensed unaudited consolidated financial statements.

Table of Contents

~~China Automotive Systems, Inc. and Subsidiaries~~

~~Notes to Condensed Unaudited Consolidated Financial Statements~~

~~Three Months and Nine Months Ended September 30, 2021 and 2020~~

1. Organization and business

China Automotive Systems, Inc., “China Automotive,” was incorporated in the State of Delaware on June 29, 1999 under the name Visions-In-Glass, Inc. China Automotive, including, when the context so requires, its subsidiaries described below, is referred to herein as the “Company.” The Company is primarily engaged in the manufacture and sale of automotive systems and components, as described below.

Great Genesis Holdings Limited, a company incorporated in Hong Kong on January 3, 2003 under the Companies Ordinance in Hong Kong as a limited liability company, “Genesis,” is a wholly-owned subsidiary of the Company.

Henglong USA Corporation, “HLUSA,” incorporated on January 8, 2007 in Troy, Michigan, is a wholly-owned subsidiary of the Company, and mainly engages in marketing of automotive parts in North America, and provides after-sales service and research and development support accordingly.

The Company owns the following aggregate net interests in the following subsidiaries organized in the People’s Republic of China, the “PRC,” and Brazil as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020.~~2021.


	Percentage Interest				Percentage Interest
	September 30,		December 31,		March 31,		December 31,
Name of Entity	2021		2020		2022		2021
Shashi Jiulong Power Steering Gears Co., Ltd., “Jiulong” ¹	100.00	%	100.00	%	100.00	%	100.00	%
Jingzhou Henglong Automotive Parts Co., Ltd., “Henglong” ²	100.00	%	100.00	%	100.00	%	100.00	%
Shenyang Jinbei Henglong Automotive Steering System Co., Ltd., “Shenyang” ³	70.00	%	70.00	%	70.00	%	70.00	%
Wuhan Jielong Electric Power Steering Co., Ltd., “Jielong” ⁴	85.00	%	85.00	%	85.00	%	85.00	%
Wuhu Henglong Automotive Steering System Co., Ltd., “Wuhu” ⁵	100.00	%	77.33	%	100.00	%	100.00	%
Hubei Henglong Automotive System Group Co., Ltd., “Hubei Henglong” ⁶	100.00	%	100.00	%	100.00	%	100.00	%
Jingzhou Henglong Automotive Technology (Testing) Center, “Testing Center” ⁷	100.00	%	100.00	%	100.00	%	100.00	%
Chongqing Henglong Hongyan Automotive System Co., Ltd., “Chongqing Henglong” ⁸	70.00	%	70.00	%	70.00	%	70.00	%
CAAS Brazil’s Imports and Trade In Automotive Parts Ltd., “Brazil Henglong” ⁹	95.84	%	95.84	%	95.84	%	95.84	%
Wuhan Chuguanjie Automotive Science and Technology Ltd., “Wuhan Chuguanjie” ¹⁰	85.00	%	85.00	%	85.00	%	85.00	%
Hubei Henglong Group Shanghai Automotive Electronics Research and Development Ltd., “Shanghai Henglong” ¹¹	100.00	%	100.00	%	100.00	%	100.00	%
Jingzhou Qingyan Intelligent Automotive Technology Research Institute Co., Ltd., “Jingzhou Qingyan”¹²	60.00	%	60.00	%	60.00	%	60.00	%
Hubei Henglong & KYB Automobile Electric Steering System Co., Ltd., “Henglong KYB”¹³	66.60	%	66.60	%	66.60	%	66.60	%
Hyoseong (Wuhan) Motion Mechatronics System Co., Ltd., “Wuhan Hyoseong”¹⁴	51.00	%	51.00	%	51.00	%	51.00	%
Wuhu Hongrun New Material Co., Ltd., “Wuhu Hongrun”¹⁵	62.00	%	62.00	%	62.00	%	62.00	%
Changchun Hualong Automotive Technology Co., Ltd., “Changchun Hualong”¹⁶	100.00	%	100.00	%	100.00	%	100.00	%

1.	Jiulong was established in 1993 and mainly engages in the production of integral power steering gears for heavy-duty vehicles.

2.	Henglong was established in 1997 and mainly engages in the production of rack and pinion power steering gears for cars and light duty vehicles.

3.	Shenyang was established in 2002 and focuses on power steering parts for light duty vehicles.

4.	Jielong was established in 2006 and mainly engages in the production and sales of automotive steering columns.

~~Table of Contents~~

Wuhu was established in 2006 and mainly engages in the production and sales of automobile steering systems. In April 2021, the Company obtained an additional 22.67% equity interest in Wuhu for total consideration of RMB 6.9 million, equivalent to approximately $1.1 million, from the other shareholder. The Company retained its controlling interest in Wuhu and the acquisition of the ~~non-controlling~~additional 22.67% equity interest in Wuhu was accounted for as an equity transaction.

Table of Contents

On March 7, 2007, Genesis established Hubei Henglong, formerly known as Jingzhou Hengsheng Automotive System Co., Ltd., its wholly-owned subsidiary, to engage in the production and sales of automotive steering systems. On July 8, 2012, Hubei Henglong changed its name to Hubei Henglong Automotive System Group Co., Ltd.

7.	In December 2009, Henglong, a subsidiary of Genesis, formed Testing Center, which mainly engages in the research and development of new products.

8.	On February 21, 2012, Hubei Henglong and SAIC-IVECO Hongyan Company, “SAIC-IVECO,” established a Sino-foreign joint venture company, Chongqing Henglong, to design, develop and manufacture both hydraulic and electric power steering systems and parts.

On August 21, 2012, Brazil Henglong was established as a Sino-foreign joint venture company by Hubei Henglong and two Brazilian citizens, Ozias Gaia Da Silva and Ademir Dal’ Evedove. Brazil Henglong engages mainly in the import and sales of automotive parts in Brazil. In May 2017, the Company obtained an additional 15.84% equity interest in Brazil Henglong for NaN consideration. The Company retained its controlling interest in Brazil Henglong and the acquisition of the non-controlling interest was accounted for as an equity transaction.

10.

In May 2014, together with Hubei Wanlong, Jielong formed a subsidiary, Wuhan Chuguanjie Automotive Science and Technology Ltd., “Wuhan Chuguanjie”, which mainly engages in research and development, manufacture and sales of automobile electronic systems and parts. Wuhan Chuguanjie is located in Wuhan, China.

11.	In January 2015, Hubei Henglong formed Hubei Henglong Group Shanghai Automotive Electronics Research and Development Ltd., “Shanghai Henglong”, which mainly engages in the design and sales of automotive electronics.

12.	In November 2017, Hubei Henglong formed Jingzhou Qingyan Intelligent Automotive Technology Research Institute Co., Ltd., “Jingzhou Qingyan”, which mainly engages in the research and development of intelligent automotive technology.

13.

In August 2018, Hubei Henglong and KYB (China) Investment Co., Ltd. (“KYB”) established Hubei Henglong KYB Automobile Electric Steering System Co., Ltd., “Henglong KYB”, which mainly engages in design, manufacture, sales and after-sales service of automobile electronic systems. Hubei Henglong owns 66.6% of the shares of this entity and has consolidated it since its establishment.

14.

In March 2019, Hubei Henglong and Hyoseong Electric Co., Ltd. established Hyoseong (Wuhan) Motion Mechatronics System Co., Ltd., “Wuhan Hyoseong”, which mainly engages in the design, manufacture and sales of automotive motors and electromechanical integrated systems. Hubei Henglong owns 51.0% of the shares of Wuhan Hyoseong and has consolidated it since its establishment.

15.	In December 2019, Hubei Henglong formed Wuhu Hongrun New Material Co., Ltd., “Wuhu Hongrun”, which mainly engages in the development, manufacturing and sale of high polymer materials. Hubei Henglong owns 62.0% of the shares of Wuhu Hongrun and has consolidated it since its establishment.

16.

In April 2020, Hubei Henglong acquired 100.0% of the equity interests of Changchun Hualong Automotive Technology Co., Ltd., “Changchun Hualong”, for total consideration of RMB 1.2 million, equivalent to approximately $0.2 million from an entity controlled by Hanlin Chen. Before the acquisition, 52.1% of the shares of Changchun Hualong were ultimately owned by Hanlin Chen and 47.9% of the shares were owned by third parties. Changchun Hualong mainly engages in design and R&D of automotive parts.

Table of Contents

2. Basis of presentation and significant accounting policies

(a)

Basis of Presentation

Basis of Presentation – The accompanying condensed unaudited consolidated financial statements include the accounts of the Company and its subsidiaries. The details of subsidiaries are disclosed in Note 1. Significant inter-company balances and transactions have been eliminated upon consolidation. The condensed unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions in Regulation S-X. Accordingly they do not include all of the information and footnotes required by such accounting principles for complete financial statements. These financial statements should be read in conjunction with the consolidated financial statements and related footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2020.~~

2021.

The accompanying interim condensed consolidated financial statements are unaudited, but in the opinion of the Company’s management, contain all necessary adjustments, which include normal recurring adjustments, for a fair statement of the results of operations, financial position and cash flows for the interim periods presented.

The condensed consolidated balance sheet as of December 31, ~~2020~~2021 is derived from the Company’s audited financial statements at that date but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements.

The results of operations for the three months ~~and nine months~~ ended ~~September 30, 2021~~March 31, 2022 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, ~~2021.~~

2022.

Estimation - The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.

Foreign Currencies - China Automotive, the parent company, and HLUSA maintain their books and records in United States Dollars, “USD,” their functional currency. The Company’s subsidiaries based in the PRC and Genesis maintain their books and records in Renminbi, “RMB,” their functional currency. The Company’s subsidiary based in Brazil maintains its books and records in Brazilian real, “BRL,” its functional currency. In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 830, foreign currency transactions denominated in currencies other than the functional currency are remeasured into the functional currency at the rate of exchange prevailing at the balance sheet date for monetary items. Nonmonetary items are remeasured at historical rates. Income and expenses are remeasured at the rate in effect on the transaction dates. Transaction gains and losses, if any, are included in the determination of net income for the period.

(b)	Recent Accounting Pronouncements

~~No accounting standards newly~~In November 2021, the FASB issued ~~during~~Accounting Standards Update (“ASU”) 2021-10 Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance, effective for financial statements issued for annual periods beginning after December 15, 2021. ASU 2021-10 requires business entities to disclose information in the ~~nine months ended September 30, 2021, had~~notes to the financial statements about certain types of government assistance. The annual disclosure requirements apply to transactions with a government that are accounted for by analogizing to either a grant model or a contribution model. We plan to adopt ASU 2020-10 when we issue our annual financial statements. We do not expect it to have a material impact on ~~the Company’s~~our consolidated financial ~~statements or disclosures.~~

statements.

(c)	Significant Accounting Policies

There have been no updates to the significant accounting policies set forth in the notes to the consolidated financial statements for the year ended December 31, ~~2020.~~

2021.

109

Table of Contents

3. Accounts and notes receivable, net

The Company’s accounts and notes receivable, net as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 are summarized as follows (figures are in thousands of USD):


	September 30, 2021		December 31, 2020		March 31, 2022		December 31, 2021
Accounts receivable - unrelated parties	$	124,743	$	141,018	$	151,245	$	146,362
Notes receivable - unrelated parties		86,610		85,354		72,643		61,328
Total accounts and notes receivable - unrelated parties		211,353		226,372		223,888		207,690
Less: allowance for doubtful accounts - unrelated parties		(11,132)		(9,853)		(12,853)		(11,961)
Accounts and notes receivable, net - unrelated parties		200,221		216,519		211,035		195,729
Accounts and notes receivable - related parties		27,494		17,622		12,256		15,505
Less: allowance for doubtful accounts - related parties		(439)		(1)		(894)		(898)
Accounts and notes receivable, net - related parties		27,055		17,621		11,362		14,607
Accounts and notes receivable, net	$	227,276	$	234,140	$	222,397	$	210,336

Notes ~~receivables~~receivable represent accounts receivable in the form of bills of exchange for which acceptances are guaranteed and settlements are handled by banks.

As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, the Company pledged its notes receivable in amounts of ~~NaN and $8.2 million, respectively, as collateral in favor of the local government for the government loans; and pledged its notes receivable in amounts of $10.0~~$19.7 million and ~~$5.5~~$18.2 million, respectively, as collateral for banks to endorse the payment of the Company’s notes payable to the noteholders upon maturity (See Note 8).

Provision for doubtful accounts and notes receivable, as provided in the unaudited consolidated statements of cash operations amounted to ~~$1.3~~$0.1 million and ~~$1.7~~$0.2 million, respectively, for the three ~~and nine~~ months ended ~~September 30, 2021, respectively.~~

~~Provision for doubtful accounts~~March 31,2022 and notes receivable reversed, as provided in the unaudited consolidated statements of operations amounted to $0.1 million and $0.3 million for the three and nine months ended September 30, 2020, respectively.2021.

During the three months ended ~~September 30, 2021,~~March 31, 2022, the Company’s 5 largest customers accounted for ~~43.0%~~46.7% of its consolidated net product sales, with one customer individually accounting for more than 10% of consolidated net sales, i.e., 17.1%. During the nine months ended September 30, 2021, the Company’s 5 largest customers accounted for 39.2% of its consolidated net product sales, with one customer accounting for more than 10% of consolidated net sales, i.e., 17.3%22.1%. As of ~~September 30, 2021,~~March 31, 2022, approximately ~~9.0%~~8.7% of accounts receivable were from trade transactions with the aforementioned customer and there was no individual customer with a receivables balance of more than 10% of total accounts receivable.

During the three months ended ~~September 30, 2020,~~March 31, 2021, the Company’s 5 largest customers accounted for ~~53.0%~~43.3% of its consolidated net product sales, with one customer accounting for more than 10% of consolidated net sales, i.e., 27.3%. During the nine months ended September 30, 2020, the Company’s 5 largest customers accounted for 47.8% of its consolidated net product sales, with one customer accounting for more than 10% of consolidated net sales, i.e., 23.5%20.9%. As of ~~September 30, 2020,~~March 31, 2021, approximately ~~10.5%~~8.8% of accounts receivable were from trade transactions with the aforementioned customer and there was no individual customer with a receivables balance of more than 10% of total accounts receivable.

~~Table of Contents~~

4. Inventories

The Company’s inventories as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 consisted of the following (figures are in thousands of USD):


	September 30, 2021		December 31, 2020		March 31, 2022		December 31, 2021
Raw materials	$	30,567	$	24,367	$	36,215	$	33,583
Work in process		9,267		10,098		10,114		9,415
Finished goods		66,593		53,860		68,154		73,495
Total	$	106,427	$	88,325	$	114,483	$	116,493

The Company recorded ~~$0.7~~$1.0 million and ~~$0.9~~$1.0 million of inventory write-down to cost of ~~product~~products sold for the three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020, respectively, and $3.0 million and $2.3 million for the nine months ended September 30, 2021 and 2020,~~ respectively.

Table of Contents

5. Long-term investments

The Company’s long-term investments ~~as of September 30, 2021~~at March 31, 2022 and December 31, ~~2020,~~2021, are summarized as follows (figures are in thousands of USD):


	September 30, 2021		December 31, 2020		March 31, 2022		December 31, 2021
Chongqing Venture Fund ⁽¹⁾	$	16,296	$	20,230
Hubei Venture Fund ⁽²⁾		11,923		14,473
Suzhou Venture Fund⁽³⁾		6,238		7,740
Beijing Henglong ⁽⁴⁾		4,053		5,241
Sentient AB⁽¹⁾						24,452		—
Chongqing Venture Fund⁽²⁾					$	15,085	$	17,530
Hubei Venture Fund ⁽³⁾						8,333		9,665
Suzhou Venture Fund⁽⁴⁾						5,634		7,413
Suzhou Qingshan ⁽⁵⁾						4,727		—
Henglong Tianyu		996		1,070		891		913
Chongqing Jinghua		532		599		578		642
Jiangsu Intelligent		704		413		960		803
Total	$	40,742	$	49,766	$	60,660	$	36,966

(1)

In June 2021, Hubei Henglong entered into a share purchase agreement with Jingzhou WiseDawn Electric Car Co., Ltd., “Jingzhou WiseDawn”, a related party controlled by the Company’s controlling shareholder, Mr. Chen Hanlin. In accordance with the agreement, CAAS would purchase 200 shares, representing 40% of Sentient AB’s share capital, from Jingzhou WiseDawn for total consideration of RMB 155.2 million, equivalent to approximately $24.5 million. The transaction was completed in March 2022. Pursuant to the share purchase agreement, the Company has the right to appoint 2 directors to the board of directors, so it can exercise significant influence over Sentient AB. Therefore, the investment is accounted for using the equity method. As of March 31, 2022, the Company has completed investment of RMB 86.0 million, equivalent to approximately $13.6 million, the remaining consideration of RMB 69.2 million, equivalent to approximately $10.9 million, will be paid in 2022.

(2)	In January ~~May, June~~ and ~~August 2021,~~February 2022, Chongqing Venture Fund made distributions that were proportional to each owner’s allocated share of the fund, pursuant to which Hubei Henglong received ~~$4.7~~$0.6 million in ~~the~~ aggregate.

~~(2)~~(3)

In ~~April 2021,~~January 2022, Hubei Venture Fund made distributions that were proportional to each owner’s allocated share of the fund, pursuant to which Hubei Henglong received ~~$2.4~~$1.2 million.

~~(3)~~(4)

In ~~August 2021,~~February 2022, Suzhou Venture Fund made distributions that were proportional to each owner’s allocated share of the fund, pursuant to which Hubei Henglong received ~~$1.4~~$0.9 million.

~~(4)~~(5)

In January ~~2021, Beijing Henglong made distributions that were proportional to each owner’s allocated share of the fund, pursuant to which~~2022, Hubei Henglong ~~received $1.5 million.~~entered into an agreement with other parties to establish a limited partnership, Suzhou Qingshan Zhiyuan Ventrue Capital Fund L.P., “Suzhou Qingshan”. As of March 31, 2022, Hubei Henglong has paid RMB 30.0 million, equivalent to approximately $4.7 million, representing 27.78% of Suzhou Qingshan’s equity. As a limited partner, Hubei Henglong has more than virtually no influence over Suzhou Qingshan’s operating and financial policies. The investment is accounted for using the equity method.

The condensed financial information of the Company’s significant equity investees for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~ are summarized as follows (figures are in thousands of USD):


	Three				Nine
	Months Ended				Months Ended
	September 30,				September 30,				Three Months Ended March 31,
	2021		2020		2021		2020		2022		2021
Revenue	$	3,811	$	22,197	$	5,937	$	22,197	$	—	$	—
Gross profit		3,811		22,197		5,937		22,197		—		—
Income from continuing operations		3,805		22,202		5,318		22,019
Net income	$	3,805	$	22,202	$	5,318	$	22,019
(Loss) from continuing operations										(20,578)		(9,093)
Net (loss)									$	(20,578)	$	(9,093)

1211

Table of Contents

6. Property, plant and equipment, net

The Company’s property, plant and equipment, net as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 are summarized as follows (figures are in thousands of USD):


	September 30, 2021		December 31, 2020		March 31, 2022		December 31, 2021
Costs:
Buildings	$	68,687	$	61,035	$	71,798	$	69,554
Machinery and equipment		243,026		233,273		256,334		253,245
Electronic equipment		6,904		6,491		6,997		6,887
Motor vehicles		5,104		5,064		5,108		5,121
Construction in progress		11,396		20,813		4,979		6,583
Total amount of property, plant and equipment		335,117		326,676		345,216		341,390
Less: Accumulated depreciation ⁽¹⁾		(205,868)		(185,672)		(221,780)		(213,669)
Total amount of property, plant and equipment, net ⁽²⁾⁽³⁾	$	129,249	$	141,004	$	123,436	$	127,721

(1)	Depreciation charges were ~~$6.4~~$5.9 million and ~~$4.9~~$6.4 million for the three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020, respectively, and $19.1 million and $15.5 million for the nine months ended September 30, 2021 and 2020,~~ respectively.

(2)	As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, the Company pledged property, plant and equipment with net book value of approximately ~~$61.2~~$9.5 million and ~~$66.1~~$54.7 million, respectively, as security for its comprehensive credit facilities with banks in China.

(3)	Interest costs capitalized for the three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ were ~~$0.1~~$0.05 million and ~~$0.2~~$0.16 million, ~~respectively, and $0.5 million and $0.8 million for the nine months ended September 30, 2021 and 2020,~~ respectively.

7. Loans

Loans consist of the following as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 (figures are in thousands of USD):

September 30, 2021

December 31, 2020
Short-term bank loans ⁽¹⁾

$
42,210

$
36,575
Current portion of long-term government loan ⁽²⁾

0

7,663
Subtotal

42,210

44,238
Long-term government loans ⁽²⁾

0

7,663
Less: Current portion of long-term government loans ⁽²⁾

0

(7,663)
Subtotal

0

0
Total bank and government loans

$
42,210

$
44,238


	March 31, 2022		December 31, 2021
Short-term bank loans ⁽¹⁾	$	48,185	$	47,592

(1)

The Company entered into credit facility agreements with various banks, which were secured by property, plant and equipment and land use rights of the Company. The total credit facility amount was ~~$160.8~~$123.3 million and ~~$172.7~~$116.8 million, respectively, as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020.~~2021. As of ~~September 30, 2021~~March 31, 2022, and December 31, ~~2020,~~2021, the Company has drawn down loans with an aggregate amount of ~~$42.2~~$48.2 million and ~~$36.6~~$47.6 million, respectively. The weighted average interest rate was ~~3.4%~~3.3% and ~~3.7%~~3.5%, respectively.

~~(2)~~

On August 7 and September 3, 2019, the Company borrowed from the local government loans of RMB 20.0 million and RMB 30.0 million, equivalent to approximately $3.0 million and $4.6 million, respectively. These loans are due for repayment on September 30, 2021 and have an interest rate of 3.80% per annum. As of September 30, 2021 and December 31, 2020, Henglong pledged NaN and RMB 53.5 million, equivalent to approximately NaN and $8.2 million, respectively, of notes receivable as collateral for the local government loans (See Note 3). The Company repaid these government loans on April 15, 2021.

The Company must use the loans for the purpose as prescribed in the loan contracts. If the Company fails to do so, it will be charged penalty interest and/or trigger early repayment. The Company complied with such financial covenants as of ~~September 30, 2021.~~March 31, 2022.

1312

Table of Contents

8. Accounts and notes payable

The Company’s accounts and notes payable as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 are summarized as follows (figures are in thousands of USD):


	September 30, 2021		December 31, 2020		March 31, 2022		December 31, 2021
Accounts payable - unrelated parties	$	124,320	$	132,349	$	132,199	$	132,593
Notes payable - unrelated parties ⁽¹⁾		78,812		80,173		83,693		81,997
Accounts and notes payable - unrelated parties		203,132		212,522		215,892		214,590
Accounts and notes payable - related parties		11,975		12,730		11,784		13,464
Total	$	215,107	$	225,252	$	227,676	$	228,054

(1)

Notes payable represent payables in the form of notes issued by the bank. As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, the Company has pledged cash of ~~$34.3~~$30.0 million and ~~$30.8~~$27.8 million, respectively. As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, the Company has pledged notes receivable of ~~$10.0~~$19.7 million and ~~$5.5~~$18.2 million, respectively, as collateral for banks to endorse the payment of the Company’s notes payable to the noteholders upon maturity. The Company entered into credit facility agreements with various banks, which were secured by property, plant and equipment and land use rights of the Company. As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, the Company has used ~~$38.9~~$21.3 million and ~~$43.9~~$33.6 million credit facility, respectively, for issuing bank notes.

9. Accrued expenses and other payables

The Company’s accrued expenses and other payables as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 are summarized as follows (figures are in thousands of USD):


	September 30, 2021		December 31, 2020		March 31, 2022		December 31, 2021
Warranty reserves⁽¹⁾	$	36,921	$	36,215	$	37,128	$	36,572
Payable for the investment in Sentient AB (See Note 5)						10,905		—
Accrued expenses		7,479		8,627		6,697		5,596
Current portion of other long-term payable (See Note 10)		2,172		4,131		0		1,115
Payables for overseas transportation and custom clearance		2,720		3,278		1,731		4,548
Dividends payable to holders of non-controlling interests		463		460		473		471
Accrued interest		358		646		257		507
Other payables		2,180		2,250		1,149		1,523
Balance at end of year	$	52,293	$	55,607	$	58,340	$	50,332

(1)

The Company provides for the estimated cost of product warranties when the products are sold. Such estimates of product warranties are based on, among other things, historical experience, product changes, material expenses, services and transportation expenses arising from the manufactured products. Estimates will be adjusted on the basis of actual claims and circumstances.

For the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ the warranties activities were as follows (figures are in thousands of USD):


	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2021		2020		2022		2021
Balance at beginning of the period	$	36,537	$	34,031	$	36,215	$	32,907	$	36,572	$	36,215
Additions during the period		4,551		3,947		12,249		12,303		3,888		3,681
Settlement within the period		(4,022)		(4,480)		(11,752)		(11,218)		(3,476)		(3,645)
Foreign currency translation (gain)/loss		(145)		1,339		209		845
Foreign currency translation loss/(gain)										144		(266)
Balance at end of the period	$	36,921	$	34,837	$	36,921	$	34,837	$	37,128	$	35,985

1413

Table of Contents

10. Other long-term payable

On January 31, 2018, the Company entered into an equipment sales agreement with a third party (the ~~“buyer-lessor"~~“buyer-lessor”) and simultaneously entered into a four-year contract to lease back the equipment from the buyer-lessor. The carrying value of the equipment was RMB 91.3 million (equivalent to ~~$14.1~~$14.4 million as of ~~September 30, 2021)~~March 31, 2022) and the sales price was RMB 100.0 million (equivalent to ~~$15.4~~$15.8 million as of ~~September 30, 2021)~~March 31, 2022). Pursuant to the terms of the contract, the Company is required to pay to the buyer-lessor lease payments over four (4) years with a quarterly lease payment of approximately $1.1 million and is entitled to obtain the ownership of this equipment at a nominal price upon the expiration of the lease. The Company is of the view that the transaction does not qualify as a sale. Therefore, the transaction was accounted for as a financing transaction by the Company. As of ~~September 30, 2021, $2.2 million was recognized as other payable (See Note 9) and NaN was recognized as~~March 31, 2022, the ~~other long-term payable.~~payables have been fully paid.

11. Redeemable non-controlling interests

In September 2020, one of the Company’s subsidiaries issued shares to Hubei Venture Fund amounting to $0.7 million. The shares will be transferred to the Company and the other shareholder of the subsidiary on a pro rata basis at the holder’s option if the subsidiary fails to complete a qualified IPO in a pre-agreed period of time after their issuance with a transfer price of par plus 6% per year. $0.5 million of the shares are subject to purchase by the Company and are therefore accounted for as redeemable non-controlling interests in mezzanine equity and are accreted to the redemption value over the period starting from the issuance date.

For the three months ~~and nine months~~ ended ~~September 30,~~March 31, 2022 and 2021, the Company recognized accretion of ~~$0.007~~$0.008 million and ~~$0.021~~$0.007 million, respectively, to the redemption value of the shares over the period starting from the issuance date with a corresponding reduction to retained ~~earnings, respectively.~~earnings.

12. Additional paid-in capital

The Company’s positions in respect of the amounts of additional paid-in capital for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ are summarized as follows (figures are in thousands of USD):


	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2021		2020		2022		2021
Balance at beginning of the period	$	63,731	$	64,273	$	64,273	$	64,466	$	63,731	$	64,273
Share-based compensation		0		0		88		0		0		88
Acquisition of the non-controlling interest in Wuhu		—		—		(630)		—
Acquisition of the non-controlling interest in Universal Sensor Application Inc., “USAI”		—		—		—		(29)
Acquisition of the non-controlling interest in Changchun Hualong		0		0		0		(76)
Deemed distribution to shareholders		—		—		—		(88)
Balance at end of the period	$	63,731	$	64,273	$	63,731	$	64,273	$	63,731	$	64,361

~~13. Stock Options~~

The Company’s stock option plan was approved at the Annual Meeting of Stockholders held on June 28, 2005, and extended to June 27, 2025 at the Annual Meeting of Stockholders held on September 16, 2014. The maximum common shares available for issuance under this plan is 2,200,000. The stock incentive plan provides for the issuance, to the Company’s officers, directors, management and employees who served over three years or have given outstanding performance, of options to purchase shares of the Company’s common stock. The Company has issued 658,850 stock options under this plan, and there remain 1,541,150 stock options issuable in the future as of September 30, 2021.

Under the aforementioned plan, the stock options granted will have an exercise price equal to the closing price of the Company’s common stock traded on NASDAQ one day before the date of grant, and will expire ~~two~~ to five years after the grant date. The stock options granted during the three months ended September 30, 2021 were exercisable immediately on the grant date. Stock options will be settled in shares of the Company’s common stock upon exercise and are recorded in the Company’s consolidated balance sheets under the caption “Additional paid-in capital.” As of September 30, 2021, the Company has sufficient unissued registered common stock for settlement of the stock incentive plan mentioned above.

~~Table of Contents~~

The fair value of stock options was determined at the date of grant using the Black-Scholes option pricing model. The Black-Scholes option model requires management to make various estimates and assumptions, including expected term, expected volatility, risk-free rate, and dividend yield. The expected term represents the period of time that stock-based compensation awards granted are expected to be outstanding and is estimated based on considerations including the vesting period, contractual term and anticipated employee exercise patterns. Expected volatility is based on the historical volatility of the Company’s stock. The risk-free rate is based on the U.S. Treasury yield curve in relation to the contractual life of stock-based compensation instruments. The dividend yield assumption is based on historical patterns and future expectations for the Company dividends.

~~For the stock options granted during the nine months ended September 30, 2021, assumptions used to estimate the fair value of stock options on the grant date is as follows:~~

Issuance Date

Expected volatility

Risk-free rate

Expected term (years)

Dividend yield

February 3, 2021

76.91
%
0.46
%
5

0.00
%

The stock options granted during the nine months ended September 30, 2021 were exercisable immediately and their fair value on the grant date using the Black-Scholes option pricing model was $0.1 million. For the nine months ended September 30, 2021 and 2020, the Company recognized stock-based compensation expenses of $0.1 million and NaN, respectively.

~~The activities of stock options are summarized as follows, including granted, exercised and forfeited.~~

Weighted-

Weighted-

Average

Average

Contractual


Shares

Exercise Price

Term (years)
Outstanding - January 1, 2020

30,000

$
4.99

5
Expired

(7,500)

4.58

5
Outstanding - December 31, 2020

22,500

$
4.79

5
Granted

22,500

6.26

5
Outstanding - September 30, 2021

45,000

$
5.52

5

~~The following is a summary of the range of exercise prices for stock options that are outstanding and exercisable on September 30, 2021:~~

Outstanding Stock

Weighted Average

Weighted Average

Number of Stock
Range of Exercise Prices

Options

Remaining Life

Exercise Price

Options Exercisable
$2.37 - $6.95

45,000

1.89

5.52

45,000

~~As of September 30, 2021 and December 31, 2020, the total intrinsic value of the Company’s stock options that were exercisable was $0.2 million and $0.1 million, respectively.~~

~~For the three months and nine months ended September 30, 2021 and 2020, 0 Company’s stock options were exercised.~~

During the nine months ended September 30, 2021, the weighted average fair value of the Company’s stock options granted was $3.92. NaN stock option was granted during the three months ended September 30, 2021 and 2020. NaN stock option was granted during the nine months ended September 30, 2020.

~~14.~~13. Retained earnings

Appropriated

Pursuant to the relevant PRC laws, the profits distribution of the Company’s subsidiaries, which are based on their PRC statutory financial statements, are available for distribution in the form of cash dividends after these subsidiaries have paid all relevant PRC tax liabilities, provided for losses in previous years, and made appropriations to statutory surplus at 10% of their respective after-tax profits each year. When the statutory surplus reserve reaches 50% of the registered capital of a company, 0 additional reserve is required. For the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ 0 statutory reserve was appropriated by the subsidiaries in China.

The Company’s activities in respect of the amounts of appropriated retained earnings for the three months ended March 31, 2022 and 2021, are summarized as follows (figures are in thousands of USD):


	Three Months Ended March 31,
	2022		2021
Balance at beginning of the period	$	11,481	$	11,303
Balance at end of the period	$	11,481	$	11,303

1614

Table of Contents

The Company’s activities in respect of the amounts of appropriated retained earnings for the three and nine months ended September 30, 2021 and 2020, are summarized as follows (figures are in thousands of USD):

��

Three Months Ended September 30,

Nine Months Ended September 30,


2021

2020

2021

2020
Balance at beginning of the period

$
11,303

$
11,265

$
11,303

$
11,265
Balance at end of the period

$
11,303

$
11,265

$
11,303

$
11,265

Unappropriated

The Company’s activities in respect of the amounts of the unappropriated retained earnings for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ are summarized as follows (figures are in thousands of USD):


	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2021		2020		2022		2021
Balance at beginning of the period	$	221,897	$	216,383	$	215,491	$	221,298	$	226,363	$	215,491
Cumulative effect of accounting change - credit loss		—		—		—		(789)
Net (loss)/income attributable to parent company		(310)		2,361		6,110		(1,765)		(51)		3,213
Accretion of redeemable non-controlling interests		(7)		(3)		(21)		(3)		(8)		(7)
Balance at end of the period	$	221,580	$	218,741	$	221,580	$	218,741	$	226,304	$	218,697

~~15.~~14. Accumulated other comprehensive income

The Company’s activities in respect of the amounts of accumulated other comprehensive income for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ are summarized as follows (figures are in thousands of USD):


	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2021		2020		2022		2021
Balance at beginning of the period	$	20,519	$	(7,668)	$	17,413	$	(3,462)	$	24,717	$	17,413
Foreign currency translation adjustment attributable to parent company		(1,256)		11,849		1,850		7,643		1,348		(2,128)
Balance at end of the period	$	19,263	$	4,181	$	19,263	$	4,181	$	26,065	$	15,285

~~16.~~15. Treasury stock

Treasury stock represents shares repurchased by the Company that are no longer outstanding and are held by the Company. Treasury stock is accounted for under the cost method. On ~~August 13, 2020,~~March 29, 2022, the Board of Directors of the Company approved a share repurchase program under which the Company was permitted to repurchase up to $5.0 million of its common stock from time to time in the open market at prevailing market prices not to exceed ~~$3.50~~$4.00 per share through ~~August 12, 2021.~~March 30, 2023. As of ~~September 30, 2021,~~the report date, the Company ~~had cumulatively~~has 0t repurchased ~~322,269~~any shares of the ~~shares that were authorized to be repurchased under the program that was approved on August 13, 2020. The repurchased shares are presented as “treasury stock” on the balance sheet.~~Company’s common stock.

~~Table of Contents~~

~~17.~~16. Non-controlling interests

The Company’s activities in respect of the amounts of the non-controlling interests’ equity for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ are summarized as follows (figures are in thousands of USD):

Three Months Ended September 30,

Nine Months Ended September 30,


2021

2020

2021

2020
Balance at beginning of the period

$
15,674

$
18,603

$
16,170

$
20,250
Net income/(loss) attributable to non-controlling interests

42

(848)

(219)

(1,590)
Contribution by non-controlling shareholder of Wuhu Hongrun

0

217

0

217
Acquisition of the non-controlling interest in USAI

0

0

0

29
Acquisition of the non-controlling interest in Changchun Hualong

0

0

0

(5)
Acquisition of the non-controlling interest in Wuhu

0

0

(444)

0
Cumulative effect of accounting change - credit loss

0

0

0

(102)
Dividends declared to non-controlling interest holders of non-wholly owned subsidiaries

0

0

0

(430)
Foreign currency translation adjustment attributable to non-controlling interests

(82)

925

127

528
Balance at end of the period

$
15,634

$
18,897

$
15,634

$
18,897


	Three Months Ended March 31,
	2022		2021
Balance at beginning of the period	$	15,854	$	16,170
Net income attributable to non-controlling interests		200		18
Foreign currency translation adjustment attributable to non-controlling interests		89		(143)
Balance at end of the period	$	16,143	$	16,045

~~18.~~17. Net product sales

Revenue Disaggregation

Management has concluded that the disaggregation level is the same under both the revenue standard and the segment reporting standard. Please refer to Note ~~25.~~24.

Table of Contents

Contract Assets and Liabilities

Contract assets, such as costs to obtain or fulfill contracts, are an insignificant component of the Company’s revenue recognition process. The majority of the Company’s cost of fulfillment as a manufacturer of products is classified as inventory, fixed assets and intangible assets, which are accounted for under the respective guidance for those asset types. Other costs of contract fulfillment are immaterial due to the nature of the Company’s products and their respective manufacturing processes.

Contract liabilities are mainly customer deposits. As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, the Company has customer deposits of ~~$1.7~~$3.7 million and ~~$1.5~~$2.4 million, respectively, which were included in other current liabilities on the consolidated balance sheets. During the ~~nine~~three months ended ~~September 30, 2021, $6.0~~March 31, 2022, $2.3 million was received and ~~$5.8~~$1.0 million (including ~~$1.5~~$1.0 million from the beginning balance of customer deposits) was recognized as net product sales revenue. During the three months ended ~~September 30, 2020, $2.1~~March 31, 2021, $1.0 million was received and ~~$4.2~~$1.4 million (including ~~$3.8~~$1.4 million from the beginning balance of customer deposits) was recognized as net product sales revenue. Customer deposits represent non-refundable cash deposits for customers to secure rights to an amount of products produced by the Company under supply agreements. When the products are shipped to customers, the Company will recognize revenue and bill the customers to reduce the amount of the customer deposit liability.

~~19.~~18. Financial ~~expense,~~income/(expense), net

During the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ the Company recorded financial ~~expense,~~income/(expense), net which is summarized as follows (figures are in thousands of USD):


	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2021		2020		2022		2021
Interest income	$	227	$	393	$	748	$	1,142	$	251	$	313
Foreign exchange loss, net		(1,015)		(2,672)		(1,293)		(3,797)
Foreign exchange gain/(loss), net										1,910		(469)
Bank charges		(33)		(34)		(333)		(248)		(146)		(83)
Total financial expense, net	$	(821)	$	(2,313)	$	(878)	$	(2,903)
Total financial income/(expense), net									$	2,015	$	(239)

~~Table of Contents~~

~~20.~~19. Income/(loss) per share

Basic income per share is computed using the weighted average number of ordinary shares outstanding during the period. Diluted income per share is computed using the weighted average number of ordinary shares and dilutive ordinary share equivalents outstanding during the period. The dilutive effect of outstanding stock options is determined based on the treasury stock method.

The calculations of basic and diluted ~~(loss)/~~income per share attributable to the parent company for the three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ were as follows (figures are in thousands of USD, except share and per share amounts):

Three Months Ended September 30,


2021

2020
Numerator:




Net (loss)/income attributable to the parent company’s common shareholders - Basic and Diluted

$
(317)

$
2,358
Denominator:

Weighted average shares outstanding

30,851,776

31,112,076
Dilutive effects of stock options

0

1,298
Denominator for dilutive income per share - Diluted

30,851,776

31,113,374

Net (loss)/income per share attributable to parent company’s common shareholders - Basic

$
(0.01)

$
0.08
Net (loss)/income per share attributable to parent company’s common shareholders - Diluted

$
(0.01)

$
0.08

The calculations of basic and diluted income/(loss) per share attributable to the parent company for the nine months ended September 30, 2021 and 2020, were as follows (figures are in thousands of USD, except share and per share amounts):


	Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2022		2021
Numerator:
Net income/(loss) attributable to the parent company’s common shareholders - Basic and Diluted	$	6,089	$	(1,768)
Net (loss)/income attributable to the parent company’s common shareholders - Basic and Diluted					$	(59)	$	3,206
Denominator:
Weighted average shares outstanding		30,851,776		31,153,162		30,851,776		30,851,776
Dilutive effects of stock options		4,191		—		0		5,960
Denominator for dilutive income per share - Diluted		30,855,967		31,153,162		30,851,776		30,857,736

Net income/(loss) per share attributable to parent company’s common shareholders - Basic	$	0.20	$	(0.06)
Net income/(loss) per share attributable to parent company’s common shareholders - Diluted	$	0.20	$	(0.06)
Net (loss)/income per share attributable to parent company’s common shareholders - Basic					$	(0.00)	$	0.10
Net (loss)/income per share attributable to parent company’s common shareholders - Diluted					$	(0.00)	$	0.10

As of ~~September 30,~~March 31, 2021, the exercise prices for 30,000 outstanding stock options were above the weighted average market price of the Company’s common stock during the ~~nine~~three months ended ~~September 30,~~March 31, 2021. Therefore, these stock options were excluded from the calculation of the diluted income per share for the corresponding periods presented.

AsTable of September 30, 2020, the exercise prices for 22,500 outstanding stock options were above the weighted average market price of the Company's common stock during the three months ended September 30, 2020. Therefore, these stock options were excluded from the calculation of the diluted income per share for the corresponding periods presented.Contents

For the three months ended ~~September 30, 2021 and the nine months ended September 30, 2020,~~March 31, 2022, assumed conversion of the stock options has not been reflected in the dilutive calculation pursuant to ASC 260, ~~"Earnings~~“Earnings Per Share,"” due to the anti-dilutive effect as a result of the ~~Company's~~Company’s net loss. The effects of all outstanding share options with common share equivalents of ~~2,983 and 457~~954 shares ~~respectively,~~ have been excluded from the calculation of the diluted loss per share for the three months ended ~~September 30, 2021 and the nine months ended September 30, 2020,~~March 31, 2022, due to their anti-dilutive effect.

~~Table of Contents~~

~~21.~~20. Significant concentrations

A significant portion of the Company’s business is conducted in China where the currency is the RMB. Regulations in China permit foreign owned entities to freely convert the RMB into foreign currency for transactions that fall under the ~~"current account"~~“current account”, which includes trade related receipts and payments, interest and dividends. Accordingly, the Company’s Chinese subsidiaries may use RMB to purchase foreign currency for settlement of such ~~"current account"~~“current account” transactions without pre-approval.

China Automotive, the parent company, may depend on dividend payments from Genesis and HLUSA, which are generated from their subsidiaries in China, “China-based Subsidiaries,” after they receive payments from the China-based Subsidiaries. Regulations in the PRC currently permit payment of dividends of a PRC company only out of accumulated profits as determined in accordance with accounting standards and regulations in China. Under PRC law China-based Subsidiaries are required to set aside at least 10% of their after-tax profit based on PRC accounting standards each year to their general reserves until the cumulative amount reaches 50% of their paid-in capital. These reserves are not distributable as cash dividends, or as loans or advances. These foreign-invested enterprises may also allocate a portion of their after-tax profits, at the discretion of their boards of directors, to their staff welfare and bonus funds. Any amounts so allocated may not be distributed and, accordingly, would not be available for distribution to Genesis and HLUSA.

The PRC government also imposes controls on the convertibility of RMB into foreign currencies and, in certain cases, the remittance of currencies out of China. The China-based Subsidiaries may experience difficulties in completing the administrative procedures necessary to obtain and remit foreign currencies. If China Automotive is unable to receive dividend payments from its subsidiaries, including the China-based subsidiaries, China Automotive may be unable to effectively finance its operations or pay dividends on its shares.

Transactions other than those that fall under the ~~"current account"~~“current account” and that involve conversion of RMB into foreign currency are classified as ~~"capital account"~~“capital account” transactions; examples of ~~"capital account"~~“capital account” transactions include repatriations of investment by or loans to foreign owners, or direct equity investments in a foreign entity by a China domiciled entity. ~~"Capital account"~~“Capital account” transactions require prior approval from ~~China's~~China’s State Administration of Foreign Exchange, or SAFE, or its provincial branch to convert a remittance into a foreign currency, such as U.S. Dollars, and transmit the foreign currency outside of China.

This system could be changed at any time and any such change may affect the ability of the Company or its subsidiaries in China to repatriate capital or profits, if any, outside China. Furthermore, SAFE has a significant degree of administrative discretion in implementing the laws and has used this discretion to limit convertibility of current account payments out of China. Whether as a result of a deterioration in the Chinese balance of payments, a shift in the Chinese macroeconomic prospects or any number of other reasons, China could impose additional restrictions on capital remittances abroad. As a result of these and other restrictions under the laws and regulations of the ~~People's~~People’s Republic of China, or the PRC, the Company’s China subsidiaries are restricted in their ability to transfer a portion of their net assets to the parent. The Company has no assurance that the relevant Chinese governmental authorities in the future will not limit further or eliminate the ability of the Company’s China subsidiaries to purchase foreign currencies and transfer such funds to the Company to meet its liquidity or other business needs. Any inability to access funds in China, if and when needed for use by the Company outside of China, could have a material and adverse effect on the Company’s liquidity and its business.

2017

Table of Contents

~~22.~~21. Related party transactions and balances

Related party transactions are as follows (figures are in thousands of USD):

Related party sales

Three Months Ended September 30,

2021

2020
Merchandise sold to related parties

$
14,691

$
16,840
Materials and others sold to related parties

365

479
Rental income obtained from related parties

132

70
Total

$
15,188

$
17,389


	Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2022		2021
Merchandise sold to related parties	$	47,016	$	40,439	$	11,004	$	16,575
Materials and others sold to related parties		1,313		1,179		605		426
Rental income obtained from related parties		373		311		125		106
Total	$	48,702	$	41,929	$	11,734	$	17,107

Related party purchases

Three Months Ended September 30,

2021

2020
Materials purchased from related parties

$
6,505

$
7,012
Equipment purchased from related parties

537

280
R&D service purchased from related parties

831

0
Others purchased from related parties

0

22
Total

$
7,873

$
7,314


	Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2022		2021
Materials purchased from related parties	$	21,916	$	16,298	$	7,540	$	8,214
Equipment purchased from related parties		1,917		867		449		225
R&D service purchased from related parties		831		—
Others purchased from related parties		11		26		157		10
Total	$	24,675	$	17,191	$	8,146	$	8,449

Related party investment transaction

Related party receivables


	September 30, 2021		December 31, 2020		March 31, 2022		December 31, 2021
Accounts and notes receivable from related parties	$	27,494	$	17,622
Accounts and notes receivable, net from related parties					$	11,362	$	14,607

Related party advance payments


	September 30, 2021		December 31, 2020		March 31, 2022		December 31, 2021
Advance payments for property, plant and equipment to related parties	$	2,391	$	3,284	$	1,159	$	810
Advance payments and others to related parties		1,366		522		1,520		600
Total	$	3,757	$	3,806	$	2,679	$	1,410

Related party payables


	September 30, 2021		December 31, 2020		March 31, 2022		December 31, 2021
Accounts and notes payable	$	11,975	$	12,730	$	11,784	$	13,464
Accrued expenses and other payables to related parties						10,905		—
Total						22,689		13,464

~~Table of Contents~~

These transactions were consummated under similar terms as those with the ~~Company's third-party~~Company’s third party customers and suppliers.

As of ~~November 12, 2021,~~May 23, 2022, Hanlin Chen, the chairman of the board of directors of the Company, owns 57.9% of the common stock of the Company and has the effective power to control the vote on substantially all significant matters without the approval of other stockholders.

Table of Contents

~~23.~~22. Commitments and contingencies

Legal proceedings

On January 7, 2019, three purported stockholders of the Company filed a stockholder derivative complaint on behalf of the Company against the Company’s directors Hanlin Chen, Qizhou Wu and Guangxun Xu and former directors Arthur Wong and Robert Tung in the Delaware Court of Chancery, alleging that they had (a) breached their fiduciary duties by approving and paying excessive compensation to the non-employee directors of the Company, Arthur Wong, Guangxun Xu and Robert Tung, and (b) failed to make full and accurate disclosure of all material information with respect to director qualification and director compensation paid in 2017 in the Company’s annual proxy statement on Schedule 14A filed on October 10, 2018. The directors have engaged their own counsel to answer this complaint. On April 9, 2019, the Company moved to dismiss the complaint. The motion to dismiss was denied on July 17, 2019. In November 2020, the Company reached a settlement to resolve the lawsuit for the sum of $55,998. The Company did not admit any liability in reaching the settlement. On February 5, 2021, the Court of Chancery conducted a hearing to confirm the settlement of the stockholder derivative action. The Court entered a Final Order and Judgment approving the settlement. The Court further ordered that the plaintiffs’ application for an award of attorneys’ fees and reimbursement of litigation expenses be reduced from $100,000 to $30,000. The Court’s Final Order and Judgment is publicly available on the Court of Chancery docket. As of September 30, 2021, the Company has received above settlement of $55,998 from the directors and paid the above attorneys’ fees and reimbursement of litigation expenses.

~~Other than as described above, the~~ Company is not a party to any pending or, to the best of the Company’s knowledge, any threatened legal proceedings and no director, officer or affiliate of the Company, or owner of record of more than five percent of the securities of the Company, or any associate of any such director, officer or security holder is a party adverse to the Company or has a material interest adverse to the Company in reference to pending litigation.

Other commitments and contingencies

In addition to the bank loans, notes payables and the related interest, the following table summarizes the Company’s major commitments and contingencies as of ~~September 30, 2021~~March 31, 2022 (figures are in thousands of USD):


	Payment obligations by period										Payment obligations by period
	2021		2022		2023		Thereafter		Total		2022		2023		2024		Thereafter		Total
Obligations for investment contracts ⁽¹⁾	$	2,405	$	0	$	—	$	0	$	2,405	$	—	$	4,726	$	—	$	—	$	4,726
Obligations for purchasing and service agreements		19,633		1,332		—		0		20,965		22,925		2,004		—		—		24,929
Total	$	22,038	$	1,332	$	—	$	0	$	23,370	$	22,925	$	6,730	$	—	$	—	$	29,655

(1)

In ~~November 2019,~~January 2022, Hubei Henglong entered into an agreement with other parties and committed to purchase ~~70%~~27.78% of the shares of ~~Hefei Senye Light Plastic Technology Co., Ltd.~~Suzhou Qingshan for total consideration of RMB ~~33.6~~60.0 million, equivalent to approximately ~~$5.2~~$9.5 million. As of ~~September 30, 2021,~~March 31, 2022, Hubei Henglong has paid RMB ~~18.0~~30.0 million, equivalent to approximately ~~$2.8~~$4.7 million, which was reported in ~~other non-current assets as the transfer of shares had not been consummated.~~long term investment using equity mehod. According to the agreement, the remaining consideration of RMB ~~15.6~~30.0 million, equivalent to approximately ~~$2.4~~$4.7 million, will be paid in ~~2021.~~2023.

2423. Off-balance sheet arrangements

As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, the Company did not have any significant transactions, obligations or relationships that could be considered off-balance sheet arrangements.

~~Table of Contents~~

~~25.~~24. Segment reporting

The accounting policies of the product sectors (each entity manufactures and sells different products and represents a different product sector) are the same as those described in the summary of significant accounting policies disclosed in the Company’s ~~2020~~2021 Annual Report on Form 10-K except that the disaggregated financial results for the product sectors have been prepared using a management approach, which is consistent with the basis and manner in which management internally disaggregates financial information for the purposes of assisting them in making internal operating decisions. Generally, the Company evaluates performance based on stand-alone product sector operating income and accounts for inter-segment sales and transfers as if the sales or transfers were to third parties, at current market prices. Each product sector is considered a reporting segment.

As of ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ the Company had 15 product sectors, 67 of which were principal profit makers and were reported as separate sectors and engaged in the production and sales of power steering (Henglong, Jiulong, Shenyang, Wuhu, Henglong KYB, Hubei Henglong, and ~~Hubei~~Brazil Henglong), and 1 holding company (Genesis). The other 98 sectors were engaged in the development, manufacturing and sale of high polymer materials (Wuhu Hongrun), R&D services (Changchun Hualong), automobile steering columns (Jielong), provision of ~~after sales~~after-sales and R&D services (HLUSA), production and sale of power steering (Chongqing ~~Henglong), trade (Brazil~~ Henglong), manufacture and sales of automobile electronic systems and parts (Wuhan Chuguanjie), research and development of intelligent automotive technology (Jingzhou Qingyan) and manufacture and sales of automotive motors and electromechanical integrated systems (Wuhan Hyoseong).

~~The Company’s product sector information for the three months and nine months ended September 30, 2021 and 2020, is as follows (figures are in thousands of USD):~~

Net Product Sales

Net (Loss)/Income

Three Months Ended

Three Months Ended

September 30,

September 30,


2021

2020

2021

2020
Henglong

$
39,937

$
41,001

$
(1,820)

$
193
Jiulong

17,127

25,879

126

823
Shenyang

3,659

3,622

(251)

(5)
Wuhu

7,878

3,221

6

(100)
Hubei Henglong

31,023

37,014

563

3,239
Henglong KYB

19,095

14,298

485

(2,045)
Other Entities

24,456

16,743

1,027

150
Total Segments

143,175

141,778

136

2,255
Corporate

0

0

(172)

(678)
Eliminations

(34,944)

(27,361)

(232)

(64)
Total

$
108,231

$
114,417

$
(268)

$
1,513

Net Product Sales

Net (Loss)/Income

Nine Months Ended

Nine Months Ended

September 30,

September 30,


2021

2020

2021

2020
Henglong

$
138,151

$
100,651

$
(877)

$
(298)
Jiulong

76,248

64,948

650

(53)
Shenyang

11,988

9,860

186

330
Wuhu

17,598

8,742

117

223
Hubei Henglong

98,338

76,565

1,893

5,391
Henglong KYB

53,961

32,987

(72)

(3,484)
Other Entities

67,247

39,054

5,470

(2,370)
Total Segments

463,531

332,807

7,367

(261)
Corporate

0

0

(1,221)

(1,766)
Eliminations

(104,355)

(61,651)

(255)

(1,328)
Total

$
359,176

$
271,156

$
5,891

$
(3,355)

2319

Table of Contents

The Company’s product sector information for the three months ended March 31, 2022 and 2021, is as follows (figures are in thousands of USD):


	Net Product Sales				Net (Loss)/Income
	Three Months Ended				Three Months Ended
	March 31,				March 31,
	2022		2021		2022		2021
Henglong	$	62,003	$	49,079	$	1,199	$	799
Jiulong		17,728		33,719		(2,434)		1,000
Shenyang		3,311		4,092		(60)		353
Wuhu		8,872		4,159		2		7
Hubei Henglong		32,943		35,458		(2,837)		666
Henglong KYB		29,807		18,206		569		165
Brazil Henglong		10,484		4,915		2,815		413
Other Entities		19,849		16,322		1,147		95
Total Segments		184,997		165,950		401		3,498
Corporate		0		0		(235)		(217)
Eliminations		(48,601)		(35,609)		(17)		(50)
Total	$	136,396	$	130,341	$	149	$	3,231

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The following discussion and analysis should be read in conjunction with the Company’s condensed unaudited consolidated financial statements and the related notes thereto and the other financial information contained elsewhere in this Report.

General Overview

China Automotive Systems, Inc. is a leading power steering systems supplier for the China automobile industry. The Company has business relationships with more than sixty vehicle manufacturers, including China’s top ranking domestic automobile manufacturers such as JAC motors, Changan Automobile Group, BAIC Group, Dongfeng Group, Brilliance Jinbei, Chery, BYD and Zhejiang Geely, as well as Sino-foreign or foreign automobile manufacturer such as General Motors, Citroen, Fiat Chrysler North America and Ford. Starting in 2008, the Company has supplied power steering gears to the Sino-foreign joint ventures established by GM, Citroen and Volkswagen in China. The Company has supplied power steering gear to Fiat Chrysler North America since 2009 and to Ford Motor Company since 2016.

Most of the Company’s production and research and development institutes are located in China. As of ~~September 30, 2021,~~March 31, 2022, the Company has approximately ~~4,529~~4,051 employees dedicated to design, development, manufacture and sales of its products. By leveraging its extensive experience, innovative technology and geographic strengths, the Company aims to grow leading positions in automotive power steering systems and to further improve overall margins, long-term operating profitability and cash flows. To achieve these goals and to respond to industry factors and trends, the Company is continuing work to improve its operations and business structure and achieve profitable growth.

In addition, as a result of COVID-19, the Company’s businesses, results of operations, financial position and cash flows had been materially and adversely affected in the first quarter of ~~2020.~~2022. The Company resumed operation in March of ~~2020.~~2022. However, because of the significant uncertainties surrounding COVID-19, which are still evolving, the extent of the business disruption, including the duration and the related financial impact on subsequent periods cannot be reasonably estimated at this time. See “Item 1A. Risk Factors—Our business operations have been and may continue to be materially and adversely affected by the outbreak of the coronavirus disease (COVID-19)” in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2020.~~2021.

Corporate Structure

The Company, through its subsidiaries, engages in the manufacture and sales of automotive systems and components. Great Genesis Holdings Limited, a company incorporated in Hong Kong on January 3, 2003 under the Companies Ordinance of Hong Kong as a limited liability company, “Genesis,” is a wholly-owned subsidiary of the Company and the holding company of the Company’s joint ventures in the PRC. Henglong USA Corporation, “HLUSA,” incorporated on January 8, 2007 in Troy, Michigan, is a wholly-owned subsidiary of the Company, and mainly engages in marketing of automotive parts in North America, and provides after-sales service and research and development support. CAAS Brazil’s Imports And Trade In Automotive Parts Ltd., “Brazil Henglong,” was established by Hubei Henglong Automotive System Group Co., Ltd., formerly known as Jingzhou Hengsheng Automotive System Co., Ltd., “Hubei Henglong,” as a Sino-foreign joint venture company with two Brazilian citizens in Brazil in August 2012. In May 2017, the Company obtained an additional 15.84% equity interest in Brazil Henglong for nil consideration. The Company retained its controlling interest in Brazil Henglong and the acquisition of the non-controlling interest was accounted for as an equity transaction. Fujian Qiaolong was acquired by the Company in the second quarter of 2014, as a joint venture company that mainly manufactures and distributes drainage and rescue vehicles with mass flow, drainage vehicles with vertical downhole operation, crawler-type mobile pump stations,high-altitude water supply and discharge drainage vehicles, long-range control crawler-type mobile pump stations and other vehicles, which was disposed of by the Company in the second quarter of 2016. USAI was established in 2005, and the Company and Hubei Wanlong owned 83.34% and 16.66%, respectively. In May 2020, USAI merged with and into Wuhan Chuguanjie, a wholly-owned subsidiary of Wuhan Jielong, and it deregistered from the local business administration on April 28, 2020. Following the merger, 85.0% of Wuhan Chuguanjie was owned by the Company and 15.0% was owned by Hubei Wanlong. In April 2020, Hubei Henglong acquired 100.00% of the shares of Changchun Hualong Automotive Technology Co., Ltd., “Changchun Hualong”, for total consideration of RMB 1.20 million, equivalent to approximately $0.2 million. Changchun Hualong mainly engages in design and R&D of automotive parts. Wuhu Hongrun New Material Co., Ltd., “Wuhu Hongrun” was formed in December 2019, which mainly engages in the development, manufacturing and sale of high polymer materials. In April 2021, the Company obtained an additional 22.67% equity interest in Wuhu, for total consideration of RMB 6.9 million, equivalent to approximately $1.1 million, from the other shareholder. Following the acquisition, the Company owned 100% of the equity interests of ~~Wuhu.~~Wuhu Henglong.

2421

Table of Contents

Critical Accounting Estimates

The Company prepares its condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amount of revenues and expenses during the reporting periods. Management periodically evaluates the estimates and judgments made. Management bases its estimates and judgments on historical experience and on various factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates as a result of different assumptions or conditions. The following critical accounting policies affect the more significant judgments and estimates used in the preparation of the Company’s condensed consolidated financial statements.

The Company considers an accounting estimate to be critical if:

●

It requires the Company to make assumptions about matters that were uncertain at the time it was making the estimate, and

●

Changes in the estimate or different estimates that the Company could have selected would have had a material impact on the Company’s financial condition or results of operations.

The table below presents information about the nature and rationale for the Company’s critical accounting estimates:


Balance Sheet Caption	Critical Estimate Item	Nature of Estimates Required	Assumptions/Approaches Used	Key Factors
Accrued liabilities and other long-term liabilities	Warranty obligations	Estimating warranty requires the Company to forecast the resolution of existing claims and expected future claims on products sold. OEMs (Original Equipment Manufacturers) are increasingly seeking to hold suppliers responsible for product warranties, which may impact the Company’s exposure to these costs.	The Company bases its estimate on historical trends of units sold and payment amounts, combined with its current understanding of the status of existing claims and discussions with its customers.	●OEM sourcing ●OEM policy decisions regarding warranty claims

Property, plant and equipment, intangible assets and other long-term assets	Valuation of long- lived assets and investments	The Company is required from time to time to review the recoverability of certain of its assets based on projections of anticipated future cash flows, including future profitability assessments of various product lines.	The Company estimates cash flows using internal budgets based on recent sales data, independent automotive production volume estimates and customer commitments.	●Future production estimates ●Customer preferences and decisions

Accounts receivable	Allowance for doubtful accounts	The Company is required from time to time to review the credit of customers and make timely provision of allowance for doubtful accounts.	The Company estimates the ~~collectability~~collect-ability of the receivables based on the future cash flows using historical experiences.	Customer credit

Inventory	Write-down of inventory	The Company is required from time to time to review the cash ability of inventory based on projections of anticipated future cash flows, including write-down of inventory for prices that are higher than market price and undesirable inventories.	The Company estimates cash flows using internal budgets based on recent sales data, independent automotive production volume estimates and customer commitments.	·●Future production estimates ·●Customer preferences and decisions

Deferred income taxes	Recoverability of deferred tax assets	The Company is required to estimate whether recoverability of its deferred tax assets is more likely than not based on forecasts of taxable earnings in the related tax jurisdiction.	The Company uses historical and projected future operating results, based upon approved business plans, including a review of the eligible carry forward period, tax planning opportunities and other relevant considerations.	·●Tax law changes ·●Variances in future projected profitability, including by taxing entity

Recent Accounting Pronouncements

Please see Note 2 to the consolidated financial statements under Item 1 of Part I of this report.

2522

Table of Contents

Results of Operations -

Three Months Ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~

Selected highlights from our results of operations are as follows (in thousands of U.S. dollars):



	Three Months Ended September 30,								Three Months Ended March 31,
	2021		2020		Change		Change %		2022		2021		Change		Change %
Net product sales	$	108,231	$	114,417	$	(6,186)	-5.4	%	$	136,396	$	130,341	$	6,055	4.6
Cost of products sold		91,439		100,842		(9,403)	-9.3			121,662		110,593		11,069	10.0
Gain on other sales		487		1,497		(1,010)	-67.5			931		1,316		(385)	(29.3)
Selling expenses		4,802		3,800		1,002	26.4			4,312		5,609		(1,297)	(23.1)
General and administrative expenses		6,174		5,142		1,032	20.1			4,754		4,615		139	3.0
Research and development expenses		5,712		6,072		(360)	-5.9			8,137		6,680		1,457	21.8
Other income		2,407		350		2,057	587.7
Other income, net										3,519		1,723		1,796	104.2
Interest expense		(255)		(403)		148	-36.7			402		343		59	17.2
Financial (income)/expense, net										(2,015)		239		(2,254)	(943.1)
Income taxes		2,441		(189)		2,630	-1,391.5			958		641		317	49.5
Net (loss)/income		(268)		1,513		(1,781)	-117.7
Net income/(loss) attributable to non-controlling interests		42		(848)		890	-105.0
Net income										149		3,231		(3,082)	(95.4)
Net income attributable to non-controlling interests										200		18		182	1,011.1
Net (loss)/income attributable to parent company’s common shareholders		(317)		2,358		(2,675)	-113.4	%	$	(59)		3,206	$	(3,265)	(101.8)	%

Net Product Sales and Cost of Products Sold


	Net Product Sales								Cost of Products Sold								Net Product Sales								Cost of Products Sold
	(in thousands of USD,								(in thousands of USD,								(in thousands of USD,								(in thousands of USD,
	except percentages)								except percentages)								except percentages)								except percentages)
	2021		2020		Change				2021		2020		Change				2022		2021		Change				2022		2021		Change
Henglong	$	39,937	$	41,001	$	(1,064)	-2.6	%	$	37,800	$	37,940	$	(140)	-0.4	%	$	62,003	$	49,079	$	12,924	26.3	%	$	57,441	$	45,119	$	12,322	27.3	%
Jiulong		17,127		25,879		(8,752)	-33.8			15,483		22,589		(7,106)	-31.5			17,728		33,719		(15,991)	(47.4)			17,606		30,668		(13,062)	(42.6)
Shenyang		3,659		3,622		37	1.0			3,095		2,934		161	5.5			3,311		4,092		(781)	(19.1)			2,816		3,313		(497)	(15.0)
Wuhu		7,878		3,221		4,657	144.6			7,436		2,968		4,468	150.5			8,872		4,159		4,713	113.3			8,302		3,872		4,430	114.4
Hubei Henglong		31,023		37,014		(5,991)	-16.2			25,111		32,366		(7,255)	-22.4			32,943		35,458		(2,515)	(7.1)			30,122		29,485		637	2.2
Henglong KYB		19,095		14,298		4,797	33.6			17,163		14,764		2,399	16.2			29,807		18,206		11,601	63.7			27,321		16,895		10,426	61.7
Brazil Henglong																		10,484		4,915		5,569	113.3			9,498		3,336		6,162	184.7
Other Entities		24,456		16,743		7,713	46.1			19,824		13,706		6,118	44.6			19,849		16,322		3,527	21.6	��		16,044		13,402		2,642	19.7
Total Segments		143,175		141,778		1,397	1.0			125,912		127,267		(1,355)	-1.1			184,997		165,950		19,047	11.5			169,150		146,090		23,060	15.8
Elimination		(34,944)		(27,361)		(7,583)	27.7			(34,473)		(26,425)		(8,048)	30.5			(48,601)		(35,609)		(12,992)	36.5			(47,488)		(35,497)		(11,991)	33.8
Total	$	108,231	$	114,417	$	(6,186)	-5.4	%	$	91,439	$	100,842	$	(9,403)	-9.3	%	$	136,396	$	130,341	$	6,055	4.6	%	$	121,662	$	110,593	$	11,069	10.0	%

Net Product Sales

Net product sales were ~~$108.2~~$ 136.4 million for the three months ended ~~September 30, 2021,~~March 31, 2022, compared to ~~$114.4~~$130.3 million for the same period in ~~2020,~~2021, representing ~~a decrease~~an increase of ~~$6.2~~$6.1 million, or ~~5.4%, mainly due to the decline in market demand as a result of the chips shortage and other overall auto market trends.~~4.7%.

Net sales of traditional steering products and parts were ~~$78.8~~$95.4 million for the three months ended ~~September 30, 2021,~~March 31, 2022, compared to ~~$97.7~~$105.6 million for the same period in ~~2020,~~2021, representing a decrease of ~~$18.9~~$10.2 million, or ~~19.3%~~9.7%. Net sales of electric power steering (“EPS”) were ~~$29.4~~$41.0 million for the three months ended ~~September 30, 2021~~March 31, 2022 and ~~$16.7~~$24.7 million for the same period in ~~2020,~~2021, representing an increase of ~~$12.7~~$16.3 million, or ~~76.0%~~66.0%. As a percentage of net sales, sales of EPS were ~~27.2%~~30.1% for the three months ended ~~September 30, 2021,~~March 31, 2022, compared with ~~14.6%~~19.0% for the same period in ~~2020.~~2021.

The ~~decrease~~increase in net product sales was due to the effects of three major factors: i) the ~~decrease~~increase in sales volume led to a sales ~~decrease~~increase of ~~$11.3~~$2.2 million due to the ~~decline~~Company’s increased sales in ~~market demand as a result of the chips shortage and other overall auto market trends;~~foreign markets; ii) the ~~decrease~~increase in average selling price of steering gears led to a sales ~~decrease~~increase of ~~$3.5~~$0.5 million; and iii) the appreciation of the RMB against the U.S. dollar in this quarter compared to the same quarter last year resulted in a sales increase of ~~$8.6~~$3.4 million.

2623

Table of Contents

Further analysis by segment (before elimination) is as follows:

●

Henglong mainly engages in providing passenger vehicle steering systems. Net product sales for Henglong were ~~$39.9~~$62.0 million for the three months ended ~~September 30, 2021,~~March 31, 2022, compared with ~~$41.0~~$49.1 million for the three months ended ~~September 30, 2020,~~March 31, 2021, representing ~~a decrease~~an increase of ~~$1.1~~$12.9 million, or ~~2.7%~~26.3%. An increase in sales volume led to a sales increase of ~~$1.3~~$12.3 million, a decrease in selling price led to a sales decrease of ~~$5.0~~$0.4 million, and the effect of foreign currency translation of the RMB against the U.S. dollar led to a sales increase of ~~$2.6~~$1.0 million.

●

Jiulong mainly engages in providing commercial vehicle steering systems. Net product sales for Jiulong were ~~$17.1~~$17.7 million for the three months ended ~~September 30, 2021,~~March 31, 2022, compared with ~~$25.9~~$33.7 million for the three months ended ~~September 30, 2020,~~March 31, 2021, representing a decrease of ~~$8.8~~$16.0 million, or ~~34.0%~~47.5%. A decrease in sales volume led to a sales decrease of ~~$9.9~~$17.7 million, an increase in selling price led to a sales increase of $1.0 million, and the effect of foreign currency translation of the RMB against the U.S. dollar led to a sales increase of ~~$1.1~~$0.7 million.

●

Shenyang mainly engages in providing vehicle steering systems to Shenyang Brilliance Jinbei Automobile Co., Ltd. (“Jinbei”), one of the major automotive manufacturers in China. Net product sales for Shenyang were ~~$3.7~~$3.3 million for the three months ended ~~September 30, 2021,~~March 31, 2022, compared to ~~$3.6~~$4.1 million for the same period in ~~2020,~~2021, representing ~~an increase~~a decrease of ~~$0.1~~$0.8 million, or ~~2.8%,~~19.5%. A decrease in sales volume led to a sales decrease of $0.4 million, a decrease in selling price led to a sales decrease of $0.5 million, and the effect of foreign currency translation of the RMB against the U.S. dollar led to a sales increase of $0.1 million.

●

Wuhu mainly engages in providing vehicle steering systems to Chery Automobile Co., Ltd. (“Chery”), one of the major automotive manufacturers in China. Net product sales for Wuhu were ~~$7.9~~$ 8.9 million for the three months ended ~~September 30, 2021,~~March 31, 2022, compared to ~~$3.2~~$4.2 million for the same period in ~~2020,~~2021, representing an increase of $4.7 ~~million.~~million, or 111.9%. An increase in sales volumes led to a sales increase of ~~$4.1~~$3.9 million, an increase in selling prices led to a sales increase of $0.7 million, and the effect of foreign currency translation of the RMB against the U.S. dollar led to a sales increase of $0.1 million.

●

Hubei Henglong mainly engages in providing vehicle steering systems to Chrysler and Ford. Net product sales for Hubei Henglong were $ 32.9 million for the three months ended March 31, 2022, compared with $35.5 million for the three months ended March 31, 2021, representing a decrease of $2.6 million, or 7.3%. A decrease in sales volume led to a sales decrease of $5.8 million, an increase in selling price led to a sales increase of $2.5 million, and the effect of foreign currency translation of the RMB against the U.S. dollar led to a sales increase of $0.7 million.

●

Henglong KYB mainly engages in providing passenger EPS products. Net product sales for Henglong KYB were $29.8 million for the three months ended March 31, 2022, compared with $18.2 million for the three months ended March 31, 2021, representing an increase of $11.6 million, or 63.7%. An increase in sales volume led to a sales increase of $12.9 million, a decrease in selling price led to a sales decrease of $1.8 million, and the effect of foreign currency translation of the RMB against the U.S. dollar led to a sales increase of $0.5 million.

●

~~Hubei Henglong mainly engages in providing vehicle steering systems to Chrysler and Ford.~~ Net product sales for ~~Hubei~~Brazil Henglong were ~~$31.0~~$10.5 million for the three months ended ~~September 30, 2021,~~March 31, 2022, compared ~~with $37.0~~to $4.9 million for the ~~three months ended September 30, 2020, representing a decrease of $6.0 million, or 16.2%. A decrease~~same period in sales volume led to a sales decrease of $13.7 million, an increase in selling price led to a sales increase of $5.7 million, and the effect of foreign currency translation of the RMB against the U.S. dollar led to a sales increase of $2.0 million.

●

~~Henglong KYB mainly engages in providing passenger EPS products. Net product sales for Henglong KYB were $19.1 million for the three months ended September 30,~~ 2021, ~~compared with $14.3 million for the three months ended September 30, 2020,~~ representing an increase of ~~$4.8~~$5.6 million, or ~~33.6 %. An increase~~114.3%, mainly caused by increases in sales volume led to a sales increase of $8.4 million, a decrease in selling price led to a sales decrease of $4.8 million, and the effect of foreign currency translation of the RMB against the U.S. dollar led to a sales increase of $1.2 million.volume.

●

Net product sales for other entities were ~~$24.5~~$19.8 million for the three months ended ~~September 30, 2021,~~March 31, 2022, compared to ~~$16.7~~$16.3 million for the same period in ~~2020,~~2021, representing an increase of ~~$7.8~~$3.5 million, or ~~46.7%~~21.5%, mainly caused by increases in sales of ~~Jielong and Brazil Henglong.~~Jielong.

2724

Table of Contents

Cost of Products Sold

For the three months ended ~~September 30, 2021,~~March 31, 2022, the cost of products sold was ~~$91.4~~$121.7 million, compared to ~~$100.8~~$110.6 million for the same period of ~~2020,~~2021, representing ~~a decrease~~an increase of ~~$9.4~~$11.1 million, or ~~9.3%~~10.0%. The ~~decrease~~increase in cost of sales was mainly due to the effect of the following major factors: i)(i) the ~~decrease~~increase in sales ~~volumes~~volume led to a cost of sales ~~decrease~~increase of ~~$11.7~~$4.1 million; ~~ii) the decrease~~(ii) an increase in unit ~~price led to~~cost resulting in a cost of sales ~~decrease~~increase of ~~$5.3~~$4.0 million; and iii) the appreciation of the RMB against the U.S. dollar resulted in a cost of sales increase of ~~$7.6~~$3.0 million. Further analysis is as follows:

●

Cost of products sold for Henglong was ~~$37.8~~$57.4 million for the three months ended ~~September 30, 2021,~~March 31, 2022, compared to ~~$37.9~~$45.1 million for the same period of ~~2020,~~2021, representing ~~a decrease~~an increase of ~~$0.1~~$12.3 million, or ~~0.3%~~27.3%. The ~~decrease~~increase in cost of sales was mainly due to an increase in sales volumes resulting in a cost of sales increase of $1.1 million, a decrease in unit cost resulting in a cost of sales decrease of $3.7 million, and the effect of foreign currency translation of the RMB against the U.S. dollar resulting in a cost of sales increase of $2.5 million.

●

Cost of products sold for Jiulong was $15.5 million for the three months ended September 30, 2021, compared to $22.6 million for the same period of 2020, representing a decrease of $7.1 million, or 31.4%. The decrease in cost of sales was mainly due to a decrease in sales volumes resulting in a cost of sales decrease of $9.3$9.2 million, an increase in unit cost resulting in a cost of sales increase of ~~$1.2~~$2.1 million, and the effect of foreign currency translation of the RMB against the U.S. dollar resulting in a cost of sales increase of $1.0 million.

●

Cost of products sold for ~~Shenyang~~Jiulong was ~~$3.1~~$17.6 million for the three months ended ~~September 30, 2021,~~March 31, 2022, compared to ~~$2.9~~$30.7 million for the same period of 2020, representing an increase of $0.2 million, or 6.9%. The increase in cost of sales was mainly due to the effect of foreign currency translation of the RMB against the U.S. dollar resulting in a cost of sales increase of $0.2 million.

●

~~Cost of products sold for Wuhu was $7.4 million for the three months ended September 30,~~ 2021, compared to $3.0 million for the same period of 2020, representing an increase of $4.4 million. The increase in cost of sales was mainly due to an increase in sales volumes resulting in a cost of sales increase of $3.8 million, an increase in unit cost resulting in a cost of sales increase of $0.1 million and the effect of foreign currency translation of the RMB against the U.S. dollar resulting in a cost of sales increase of $0.5 million.

●

~~Cost of products sold for Hubei Henglong was $25.1 million for the three months ended September 30, 2021, compared to $32.4 million for the same period of 2020,~~ representing a decrease of ~~$7.3~~$13.1 million, or ~~22.5%~~42.7%. The decrease in cost of sales was mainly due to a decrease in sales volumes resulting in a cost of sales decrease of ~~$10.4~~$15.6 million, an increase in unit cost resulting in a cost of sales increase of ~~$1.6 million, and the effect of foreign currency translation of the RMB against the U.S. dollar resulting in a cost of sales increase of $1.5 million.~~

●

Cost of products sold for Henglong KYB was $17.2 million for the three months ended September 30, 2021, compared to $14.8 million for the same period of 2020, representing an increase of $2.4 million, or 16.2%. The increase in cost of sales was mainly due to an increase in sales volumes resulting in a cost of sales increase of $8.7 million, a decrease in unit cost resulting in a cost of sales decrease of $7.4 million, and the effect of foreign currency translation of the RMB against the U.S. dollar resulting in a cost of sales increase of $1.1 million.

●	Cost of products sold for other entities was $19.8 million for the three months ended September 30, 2021, compared to $13.7 million for the same period in 2020, representing an increase of $6.1 million, or 44.5%.

Gross margin was 15.5% for the three months ended September 30, 2021, compared to 11.9% for the same period of 2020, representing an increase of 3.6%, mainly due to the changes in the product mix for the three months ended September 30, 2021.

~~Selling Expenses~~

Selling expenses were $4.8 million for the three months ended September 30, 2021, as compared to $3.8 million for the same period of 2020, representing an increase of $1.0 million, or 26.3%, which was primarily due to the increase in logistic expenses and higher payroll expenses.

~~Table of Contents~~

~~General and Administrative Expenses~~

General and administrative expenses were $6.2 million for the three months ended September 30, 2021, as compared to $5.1 million for the same period of 2020, representing an increase of $1.1 million, or 21.6%, which was mainly due to the increased bad debt provision for accounts receivable.

~~Research and Development Expenses~~

Research and development expenses were $5.7 million for the three months ended September 30, 2021, as compared to $6.1 million for the same period of 2020, representing a decrease of $0.4 million, or 6.6%, which was primarily due to lower payroll expenses.

~~Other Income~~

Other income, net was $2.4 million for the three months ended September 30, 2021, as compared to $0.4 million for the three months ended September 30, 2020, representing an increase of $2.0 million, which was mainly due to the various government subsidies of $1.8 million received in the third quarter of 2021, whereas only $0.2 million was received in the same period of last year.

~~Interest Expense~~

~~Interest expense was $0.3 million for the three months ended September 30, 2021, which is consistent with to $0.4 million for the three months ended September 30, 2020.~~

~~Income Taxes~~

Income tax expense was $2.4 million for the three months ended September 30, 2021, compared to income tax benefit of $0.2 million for the three months ended September 30, 2020, which was primarily due to the increase in valuation allowance recognized in the three months ended September 30, 2021.

~~Net income/(loss) Attributable to Non-controlling Interests~~

Net income attributable to non-controlling interests amounted to $0.1 million for the three months ended September 30, 2021, compared to net loss of $0.8 million for the three months ended September 30, 2020.

~~Net Income/(loss) Attributable to Parent Company’s Common Shareholders~~

Net loss attributable to parent company’s common shareholders was $0.3 million for the three months ended September 30, 2021, compared to net income attributable to parent company’s common shareholders of $2.4 million for the three months ended September 30, 2020, representing a decrease in net income of $2.7 million.

~~Table of Contents~~

~~Results of Operations - Nine Months Ended September 30, 2021 and 2020~~

~~Selected highlights from our results of operations are as follows (in thousands of U.S. dollars):~~

Nine Months Ended September 30,


2021

2020

Change

Change%

Net product sales

$
359,176

$
271,156

$
88,020

32.5
%
Cost of products sold

306,807

238,598

68,209

28.6

Gain on other sales

2,528

2,935

(407)

-13.9

Selling expenses

14,857

8,895

5,962

67.0

General and administrative expenses

16,852

13,330

3,522

26.4

Research and development expenses

18,318

17,390

928

5.3

Other income, net

5,636

1,724

3,912

226.9

Interest expense

(892)

(1,214)

322

-26.5

Income taxes

3,280

294

2,986

1,015.6

Net income/(loss)

5,891

(3,355)

9,246

-275.6

Net loss attributable to non-controlling interests

(219)

(1,590)

1,371

-86.2

Net (loss)/income attributable to parent company’s common shareholders

6,089

(1,768)

7,857

-444.4
%

~~Net Product Sales and Cost of Products Sold~~

Net Product Sales

Cost of Products Sold

(in thousands of USD,

(in thousands of USD,

except percentages)

except percentages)


2021

2020

Change

2021

2020

Change

Henglong

$
138,151

$
100,651

$
37,500

37.3
%
$
128,793

$
94,069

$
34,724

36.9
%
Jiulong

76,248

64,948

11,300

17.4

69,782

59,759

10,023

16.8

Shenyang

11,988

9,860

2,128

21.6

9,843

8,111

1,732

21.4

Wuhu

17,598

8,742

8,856

101.3

16,170

7,735

8,435

109.0

Hubei Henglong

98,338

76,565

21,773

28.4

80,396

63,740

16,656

26.1

Henglong KYB

53,961

32,987

20,974

63.6

49,954

32,907

17,047

51.8

Other Entities

67,247

39,054

28,193

72.2

55,586

31,591

23,995

76.0

Total Segments

463,531

332,807

130,724

39.3

410,524

297,912

112,612

37.8

Elimination

(104,355)

(61,651)

(42,704)

69.3

(103,717)

(59,314)

(44,403)

74.9

Total

$
359,176

$
271,156

$
88,020

32.5
%
$
306,807

$
238,598

$
68,209

28.6
%

~~Net Product Sales~~

Net product sales were $359.2 million for the nine months ended September 30, 2021, compared to $271.2 million for the same period of 2020, representing an increase of $88.0 million, or 32.4%, mainly due to the market recovery from COVID-19.

Net sales of traditional steering products and parts were $281.9 million for the nine months ended September 30, 2021, compared to $231.1 million for the same period in 2020, representing an increase of $50.8 million, or 22.0 %. Net sales of electric power steering (“EPS”) were $77.3 million for the nine months ended September 30, 2021 and $40.1 million for the same period in 2020, representing an increase of $37.2 million, or 92.8%. As a percentage of net sales, sales of EPS were 21.5 % for the nine months ended September 30, 2021, compared to 14.8% for the same period in 2020.

The increase in net product sales was due to the effects of three major factors: i) the increase in sales volume led to a sales increase of $80.0 million due to the increase in demand as a result of the recovery of manufacturing and operations of the Company’s customers from the economic effects of COVID-19; ii) the decrease in average selling price of steering gears led to a sales decrease of $11.9 million; and iii) the depreciation of the RMB against the U.S. dollar in this period compared to the same period last year resulted in a sales increase of $19.9 million.

~~Table of Contents~~

~~Further analysis by segment (before elimination) is as follows:~~

●

Henglong mainly engages in providing passenger vehicle steering systems. Net product sales for Henglong were $138.2 million for the nine months ended September 30, 2021, compared with $100.7 million for the nine months ended September 30, 2020, representing an increase of $37.5 million, or 37.2 %. An increase in sales volume led to a sales increase of $40.3 million, a decrease in selling price led to a sales decrease of $9.5 million, and the effect of foreign currency translation of the RMB against the U.S. dollar led to a sales increase of $6.7 million.

●

Jiulong mainly engages in providing commercial vehicle steering systems. Net product sales for Jiulong were $76.2 million for the nine months ended September 30, 2021, compared with $65.0 million for the nine months ended September 30, 2020, representing an increase of $11.2 million, or 17.2%.The increase was primarily due to the increased demand in the China commercial vehicle market after the COVID-19 pandemic along with China’s economic stimulus policies. An increase in sales volume led to a sales increase of $2.9 million, an increase in selling price led to a sales increase of $4.2 million, and the effect of foreign currency translation of the RMB against the U.S. dollar led to a sales increase of $4.1 million.

●

Shenyang mainly engages in providing vehicle steering systems to Shenyang Brilliance Jinbei Automobile Co., Ltd., “Jinbei”, one of the major automotive manufacturers in China. Net product sales for Shenyang were $12.0 million for the nine months ended September 30, 2021, compared to $9.9 million for the same period in 2020, representing an increase of $2.1 million, or 21.2%. An increase in sales volumes led to a sales increase of $1.6 million, a decrease in selling price led to a sales decrease of $0.1 million, and the effect of foreign currency translation of the RMB against the U.S. dollar led to a sales increase of $0.6 million.

●

Wuhu mainly engages in providing vehicle steering systems to Chery Automobile Co., Ltd., “Chery”, one of the major automotive manufacturers in China. Net product sales for Wuhu were $17.6 million for the nine months ended September 30, 2021, compared to $8.7 million for the same period in 2020, representing an increase of $8.9 million. An increase in sales volume led to a sales increase of $9.4 million, a decrease in selling price led to a sales decrease of $1.5 million, and the effect of foreign currency translation of the RMB against the U.S. dollar led to a sales increase of $1.0 million.

●

Hubei Henglong mainly engages in providing vehicle steering systems to Chrysler and Ford. Net product sales for Hubei Henglong were $98.3 million for the nine months ended September 30, 2021, compared to $76.6 million for the same period in 2020, representing an increase of $21.7 million, or 28.3%. An increase in sales volume led to a sales increase of $5.0 million, an increase in selling price led to a sales increase of $12.6 million, and the effect of foreign currency translation of the RMB against the U.S. dollar led to a sales increase of $4.1 million.

●

Henglong KYB mainly engages in providing passenger EPS products. Net product sales for Henglong KYB were $54.0 million for the nine months ended September 30, 2021, compared with $33.0 million for the nine months ended September 30, 2020, representing an increase of $21.0 million, or 63.6%. An increase in sales volume led to a sales increase of $23.9 million, a decrease in selling price led to a sales decrease of $5.8 million, and the effect of foreign currency translation of the RMB against the U.S. dollar led to a sales increase of $2.9 million.

●	Net product sales for other entities were $67.2 million for the nine months ended September 30, 2021, compared to $39.1 million for the same period in 2020, representing an increase of $28.1 million, or 71.9%.

~~Cost of Products Sold~~

For the nine months ended September 30, 2021, the cost of products sold was $306.8 million, compared to $238.6 million for the same period of 2020, representing an increase of $68.2 million, or 28.6%. The increase in cost of sales was mainly due to the effect of the following major factors: i) the increase in sales volumes led to a cost of sales increase of $62.9 million; ii) the decrease in unit cost led to a cost of sales decrease of $15.3 million; and iii) the depreciation of the RMB against the U.S. dollar resulted in a cost of sales increase of $20.6 million. Further analysis is as follows:

●

Cost of products sold for Henglong was $128.8 million for the nine months ended September 30, 2021, compared to $94.0 million for the same period of 2020, representing an increase of $34.8 million, or 37.0%. The increase in cost of sales was mainly due to an increase in sales volumes resulting in a cost of sales increase of $36.8 million, a decrease in unit cost resulting in a cost of sales

~~Table of Contents~~

~~decrease of $8.5 million, and the effect of foreign currency translation of the RMB against the U.S. dollar resulting in a cost of sales increase of $6.5 million.~~

●

Cost of products sold for Jiulong was $69.8 million for the nine months ended September 30, 2021, compared to $59.8 million for the same period of 2020, representing an increase of $10.0 million, or 16.7%. The increase in cost of sales was mainly due to an increase in sales volumes resulting in a cost of sales increase of $1.8 million, an increase in unit cost resulting in a cost of sales increase of $4.2 million, and the effect of foreign currency translation of the RMB against the U.S. dollar resulting in a cost of sales increase of $4.0 million.

●

Cost of products sold for Shenyang was $9.8 million for the nine months ended September 30, 2021, compared to $8.1 million for the same period of 2020, representing an increase of $1.7 million, or 21.0%. The increase in cost of sales was mainly due to an increase in sales volumes resulting in a cost of sales increase of $1.3 million, a decrease in unit cost resulting in a cost of sales decrease of $0.2$1.9 million, and the effect of foreign currency translation of the RMB against the U.S. dollar resulting in a cost of sales increase of $0.6 million.

●

Cost of products sold for ~~Wuhu~~Shenyang was ~~$16.2~~$2.8 million for the ~~nine~~three months ended ~~September 30, 2021,~~March 31, 2022, compared to ~~$7.8~~$3.3 million for the same period of ~~2020,~~2021, representing ~~an increase~~a decrease of ~~$8.4 million.~~$0.5 million, or 15.2%. The ~~increase~~decrease in cost of sales was mainly due to ~~an increase~~a decrease in sales volumes resulting in a cost of sales ~~increase~~decrease of ~~$8.8~~$0.2 million, a decrease in unit cost resulting in a cost of ~~sales~~sale decrease of ~~$1.2~~$0.4 million, and the effect of foreign currency translation of the RMB against the U.S. dollar resulting in a cost of sales increase of ~~$0.8~~$0.1 million.

●

Cost of products sold for ~~Hubei Henglong~~Wuhu was ~~$80.4~~$8.3 million for the ~~nine~~three months ended ~~September 30, 2021,~~March 31, 2022, compared to ~~$63.8~~$3.9 million for the same period of ~~2020,~~2021, representing an increase of ~~$16.6~~$4.4 million, or ~~26.0%~~112.8%. The increase in cost of sales was mainly due to an increase in sales volumes resulting in a cost of sales increase of ~~$11.3~~$3.6 million, an increase in unit cost resulting in a cost of sales increase of ~~$2.0~~$0.7 million, and the effect of foreign currency translation of the RMB against the U.S. dollar resulting in a cost of sales increase of ~~$3.3~~$0.1 million.

●

Cost of products sold for Hubei Henglong was $30.1 million for the three months ended March 31, 2022, compared to $29.5 million for the same period of 2021, representing an increase of $0.6 million, or 2.0%. The increase in cost of sales was mainly due to a decrease in sales volumes resulting in a cost of sales decrease of $1.0 million, an increase in unit cost resulting in a cost of sales increase of $1.0 million, and the effect of foreign currency translation of the RMB against the U.S. dollar resulting in a cost of sales increase of $0.6 million.

●

Cost of products sold for Henglong KYB was ~~$50.0~~$27.3 million for the ~~nine~~three months ended ~~September 30, 2021,~~March 31, 2022, compared to ~~$32.9~~$16.9 million for the same period of ~~2020,~~2021, representing an increase of ~~$17.1~~$10.4 million, or ~~52.0%~~61.5%. The increase in cost of sales was mainly due to an increase in sales volumes resulting in a cost of sales increase of ~~$23.3~~$8.7 million, ~~a decrease~~an increase in unit cost resulting in a cost of sales ~~decrease~~increase of ~~$8.8~~$1.3 million, and the ~~depreciation~~effect of foreign currency translation of the RMB against the U.S. dollar resulting in a cost of sales increase of ~~$2.6~~$0.4 million.

●

Cost of products sold for Brazil Henglong was $9.5 million for the three months ended March 31, 2022, compared to $3.3 million for the same period in 2021, representing an increase of $6.2 million, or 187.9%. The increase in cost of sales was mainly due to an increase in sales volumes resulting in a cost of sales increase of $6.2 million.

●	Cost of products sold for other entities was ~~$55.6~~$16.0 million for the ~~nine~~three months ended ~~September 30, 2021,~~March 31, 2022, compared to ~~$31.6~~$13.4 million for the same period in ~~2020,~~2021, representing an increase of ~~$24.0~~$2.6 million, or ~~75.9%~~19.4%.

Gross margin was 14.6% for the nine months ended September 30, 2021, compared to 12.0% for the same period of 2020, representing an increase of 2.6%. There was a significant decline in export sales to United States, which were the Company’s highest gross margin products, due to COVID-19, which resulted in the temporary shutdown of operations of our major customers in the second quarter of 2020. As our customers in the United States began re-opening operations, the Company’s export sales volume and gross margin increased.

~~Selling Expenses~~

Selling expenses were $14.9 million for the nine months ended September 30, 2021, as compared to $8.9 million for the same period of 2020, representing an increase of $6.0 million, or 67.4%, which was primarily due to increase in logistic expenses and higher payroll expenses.

3225

Table of Contents

G~~eneral~~Gross margin was 10.8% for the three months ended March 31, 2022, compared to 15.1% for the same period of 2021, representing a decrease of 4.3%, mainly due to the changes in the product mix for the three months ended March 31, 2021.

Selling Expenses

Selling expenses were $4.3 million for the three months ended March 31, 2022, as compared to $5.6 million for the same period of 2021, representing a decrease of $1.3 million, which was primarily due to the decrease in transportation expenses.

General and Administrative Expenses

General and administrative expenses were ~~$16.9~~$4.8 million for the ~~nine~~three months ended ~~September 30, 2021,~~March 31, 2022, which is substantially consistent with $4.6 million for the three months ended March 31, 2021.

Research and Development Expenses

Research and development expenses were $8.1 million for the three months ended March 31, 2022, as compared to ~~$13.3~~$6.7 million for the same period of ~~2020,~~2021, representing an increase of ~~$3.6~~$1.4 million, or ~~27.1%, which was mainly due to the bad debt provision provided for accounts receivable and miscellaneous fees.~~

~~Research and Development Expenses~~

Research and development expenses were $18.3 million for the nine months ended September 30, 2021, as compared to $17.4 million for the nine months ended September 30, 2020, representing an increase of $0.9 million, or 5.2%20.9%, which was mainly due to increased expenditures on R&D activities for EPS products.

Other Income, net

Other income, net was ~~$5.6~~$3.5 million for the ~~nine~~three months ended ~~September 30, 2021, which was comprised of government subsidies,~~March 31, 2022, as compared to $1.7 million for the ~~nine~~three months ended ~~September 30, 2020, which was comprised of government subsidies and donation to the local government,~~March 31, 2021, representing an increase of ~~$3.9~~$1.8 million, which was mainly due to the various government subsidies of ~~$4.2~~$3.0 million received in the ~~nine months ended September 30, 2021,~~first quarter of 2022, whereas only ~~$0.7~~$1.4 million was received in the same period of ~~2020, and a donation of $1.1 million to the local government in the same period of 2020.~~last year.

Interest Expense

Interest expense was ~~$0.9~~$0.4 million for the ~~nine~~three months ended ~~September 30, 2021, compared to $1.2~~March 31, 2022, which is substantially consistent with $0.3 million for the ~~nine~~three months ended ~~September 30, 2020.~~March 31, 2021.

Financial (Income)/expense, net

Financial income, net was $2.0 million for the three months ended March 31, 2022, compared to financial expense, net of $0.2 million for the three months ended March 31, 2021, representing a decrease in financial expense of $2.2 million, which was primarily due to an increase in the foreign exchange gains due to the appreciation of the exchange rate between the Brazilian Real and the U.S. dollar.

Income Taxes

Income tax expense was ~~$3.3~~$1.0 million for the ~~nine~~three months ended ~~September 30, 2021,~~March 31, 2022, compared to ~~$0.3~~income tax expense of $0.6 million for the ~~nine~~three months ended ~~September 30, 2020,~~March 31, 2021, which was primarily due to the increase in valuation allowance recognized in the ~~nine~~three months ended ~~September 30, 2021.~~March 31, 2022.

Net ~~Loss~~Income Attributable to Non-controlling Interests

Net ~~loss~~income attributable to non-controlling interests amounted to $0.2 million for the ~~nine~~three months ended ~~September 30, 2021,~~March 31, 2022, compared to ~~net loss of $1.6~~$0.02 million for the ~~nine~~three months ended ~~September 30, 2020.~~March 31, 2021.

Net ~~Income/(loss)~~(Loss)/income Attributable to Parent Company’s Common Shareholders

Net loss attributable to parent company’s common shareholders was $0.1 million for the three months ended March 31, 2022, compared to net income attributable to parent company’s common shareholders ~~was $6.1~~of $3.2 million for the ~~nine~~three months ended ~~September 30,~~March 31, 2021, ~~compared to~~representing an increase in net loss attributable to parent company’s common shareholders of ~~$1.8 million for the nine months ended September 30, 2020, representing an increase in net income attributable to parent company’s common shareholders~~$3.3 million.

Table of ~~$7.9 million.~~Contents

Liquidity and Capital Resources

Capital Resources and Use of Cash

The Company has historically financed its liquidity requirements from a variety of sources, including short-term borrowings under bank credit agreements, bankers’ acceptances, issuances of capital stock and notes and internally generated cash. As of ~~September 30, 2021,~~March 31, 2022, the Company had cash and cash equivalents and short-term investments of ~~$94.4~~$124.0 million, compared to ~~$107.4~~$133.5 million as of December 31, ~~2020,~~2021, representing a decrease of ~~$13.0~~$9.5 million, or ~~12.1%~~7.1%.

The Company had working capital (total current assets less total current liabilities) of $145.6 million as of ~~September 30, 2021,~~March 31, 2022, compared to ~~$121.2~~$149.6 million as of December 31, ~~2020,~~2021, representing ~~an increase~~a decrease of ~~$24.4~~$4.0 million, or ~~20.1%~~2.7%.

~~Table of Contents~~

Except for the expected distribution of dividends from the Company’s PRC subsidiaries to the Company in order to fund the payment of the one-time transition tax due to the U.S. Tax Reform, the Company intends to indefinitely reinvest the funds in subsidiaries established in the PRC.

We cannot predict the impact COVID-19 may have on our cash flow for the rest of ~~2021.~~2022. However, based on our liquidity assessment, we believe that our cash flow from operations and proceeds from our financing activities will be sufficient to meet our anticipated cash needs, including our cash needs for working capital and capital expenditures, for the foreseeable future and for at least twelve months subsequent to the filing of this report.

Capital Source

The Company’s capital source is multifaceted, such as bank loans and banks’ acceptance facilities. In financing activities and operating activities, the Company’s banks require the Company to sign line of credit agreements and repay such facilities within one to two years. On the condition that the Company can provide adequate mortgage security and has not violated the terms of the line of credit agreement, such facilities can be extended for another one to two years.

The Company had short-term loans of ~~$42.2~~$48.2 million (See Note 7) and bankers’ acceptances of ~~$82.2~~$86.8 million (See Note 8) as of ~~September 30, 2021.~~March 31, 2022.

The Company currently expects to be able to obtain similar bank loans, i.e., RMB loans, and bankers’ acceptance facilities in the future if it can provide adequate mortgage security following the termination of the above-mentioned agreements, see the table under “Bank Arrangements” below for more information. If the Company is not able to do so, it will have to refinance such debt as it becomes due or repay that debt to the extent it has cash available from operations or from the proceeds of additional issuances of capital stock. Due to a depreciation of assets, the value of the mortgages securing the above-mentioned bank loans and ~~banker's~~banker’s acceptances is expected to be reduced by approximately ~~$16.4~~$16.7 million over the next 12 months. If the Company wishes to maintain the same amount of bank loans and ~~banker's~~banker’s acceptances in the future, it may be required by the banks to provide additional mortgages of ~~$16.4~~$16.7 million as of the maturity date of such line of credit agreements, see the table under “Bank Arrangements” below for more information. The Company can still obtain a reduced line of credit with a reduction of ~~$8.8~~$16.0 million, which is ~~53.9%~~95.8%, the mortgage ratio, of ~~$16.4~~$16.7 million, if it cannot provide additional mortgages. The Company expects that the reduction in bank loans will not have a material adverse effect on its liquidity.

3427

Table of Contents

Bank Arrangements

As of ~~September 30, 2021,~~March 31, 2022, the principal outstanding under the Company’s credit facilities and lines of credit was as follows (figures are in thousands of USD):


							Assessed								Assessed
		Due	Amount		Amount		Mortgage			Due	Amount		Amount		Mortgage
	Bank	Date	Available⁽³⁾		Used⁽⁴⁾		Value⁽⁵⁾		Bank	Date	Available⁽²⁾		Used⁽³⁾		Value⁽⁴⁾
1. Comprehensive credit facilities	China Everbright Bank ⁽²⁾	May 2022	$	3,084	$	964	$	9,786	China Everbright Bank ⁽¹⁾	May 2022		3,151		2,521		9,997

2. Comprehensive credit facilities	Shanghai Pudong Development Bank ⁽¹⁾⁽²⁾	Oct 2021		20,045		9,653		22,681	Shanghai Pudong Development Bank ⁽¹⁾	Jan 2023		20,478		1,261		18,354

3. Comprehensive credit facilities	China CITIC Bank ⁽²⁾	Aug 2022		65,531		40,958		20,081	China CITIC Bank ⁽¹⁾	Aug 2022		66,948		45,838		22,443
	China CITIC Bank	Jun 2022		3,331		—		6,801

4. Comprehensive credit facilities	Hubei Bank	Mar 2022		26,213		17,887		71,881	China Industrial Bank	Nov 2022		1,103		1,103		3,113

5. Comprehensive credit facilities	Bank of China ⁽²⁾	Nov 2021		17,886		6,168		6,168	Huishang Bank	May 2022		1,575		—		—

6. Comprehensive credit facilities	China Merchants Bank ⁽¹⁾⁽²⁾	Oct 2021		23,129		—		—	Bank of China ⁽¹⁾	Jun 2022		14,335		13,547		6,301

7. Comprehensive credit facilities	Agricultural Bank of China	Mar 2022		1,542		1,079		4,284	Hankou Bank ⁽¹⁾	Nov 2022		15,752		4,043		—

Total			$	160,761	$	76,709	$	141,682			$	123,342	$	68,313	$	60,208

(1)	~~These facilities have expired. The Company is currently in the process of negotiating with these banks to renew the credit facilities.~~

~~(2)~~

The comprehensive credit facilities with China Everbright Bank are guaranteed by Hubei Henglong in addition to the above pledged assets. The comprehensive credit facilities with Shanghai Pudong Development Bank are guaranteed by Henglong in addition to the above pledged assets. The comprehensive credit facilities with China CITIC Bank are guaranteed by Henglong and Hubei Henglong in addition to the above pledged assets. The comprehensive credit facilities with Bank of China are guaranteed by Hubei Henglong in addition to the above pledged assets. The comprehensive credit facilities with ~~China Merchants~~Hankou Bank are guaranteed by ~~Hubei~~ Henglong.

~~(3)~~(2)

“Amount available” is used for the drawdown of bank loans and issuance of bank notes at the Company’s discretion. If the Company elects to utilize the facility by issuance of bank notes, additional collateral is requested to be pledged to the bank.

~~(4)~~(3)

“Amount used” represents the credit facilities used by the Company for the purpose of bank loans or notes payable during the facility contract period. The loans or notes payable under the credit facilities will remain outstanding regardless of the expiration of the relevant credit facilities until the separate loans or notes payable expire. The amount used includes bank loans of ~~$42.2~~$47.0 million and notes payable of ~~$38.9~~$21.3 million as of ~~September 30, 2021.~~March 31, 2022.

~~(5)~~(4)

In order to obtain lines of credit, the Company needs to pledge certain assets to banks. As of ~~September 30, 2021,~~March 31, 2022, the pledged assets included property, plant and equipment and land use rights with an aggregate assessed value of ~~$141.7~~$60.2 million.

The Company may request the banks to issue notes payable or bank loans within its credit line using a 365-day revolving line.

Table of Contents

The Company’s bank loan terms range from 6 months to 12 months. Pursuant to the comprehensive credit line arrangement, the Company pledged and guaranteed:

1. Land use rights and buildings with an assessed value of approximately ~~$9.8~~$10.0 million as security for its comprehensive credit facility with China Everbright Bank.

~~Table of Contents~~

2. ~~Buildings~~Land use rights and buildings with an assessed value of approximately ~~$22.7~~$18.4 million as security for its revolving comprehensive credit facility with Shanghai Pudong Development Bank.

3. Land use rights and buildings with an assessed value of approximately ~~$20.1~~$22.4 million as security for its comprehensive credit facility with China CITIC Bank Wuhan Branch.

4. ~~Land use rights and buildings~~Buildings with an assessed value of approximately ~~$6.8~~$3.1 million as security for its comprehensive credit facility with China ~~CITIC Bank Shenyang Branch.~~Industrial Bank.

5. ~~Equipment with an assessed value of approximately $71.9 million as security for its revolving comprehensive credit facility with Hubei Bank.~~

6. The tax refund special bank account with an assessed value of approximately ~~$6.2~~$6.3 million as security for its comprehensive credit facility with Bank of China.

~~7. Buildings with an assessed value of approximately $4.3 million as security for its comprehensive credit facility with Agricultural Bank of China.~~

3629

Table of Contents

Short-term Loans

The following table summarizes the contract information of short-term borrowings between the banks and the Company as of ~~September 30, 2021~~March 31, 2022 (figures are in thousands of USD).


			Borrowing			Annual		Date of				Borrowing			Annual		Date of
Bank		Borrowing	Term			Interest		Interest			Borrowing	Term			Interest		Interest
Government	Purpose	Date	(Months)	Principal		Rate		Payment	Due Date	Purpose	Date	(Months)	Principal		Rate		Payment	Due Date
Bank of China										Working Capital	Sep 27, 2021	12		3,150	3.80	%	Pay monthly	Sep 27, 2022

Bank of China										Working Capital	Nov 24, 2021	12		4,096	3.80	%	Pay monthly	Nov 24, 2022

Bank of China										Working Capital	Aug 27, 2021	12		3,150	3.80	%	Pay monthly	Aug 26, 2022

Bank of China										Working Capital	Oct 27, 2021	12		3,150	3.80	%	Pay monthly	Oct 26, 2022

China CITIC Bank ⁽¹⁾										Working Capital	Apr 29, 2021	12		1,575	4.35	%	Pay monthly	Apr 29, 2022

China CITIC Bank ⁽¹⁾										Working Capital	May 21, 2021	12		1,575	4.35	%	Pay monthly	May 21, 2022

China CITIC Bank										Working Capital	May 28, 2021	12		1,575	4.35	%	Pay monthly	May 28, 2022

China Industrial Bank										Working Capital	Dec 22, 2021	12		1,103	3.85	%	Pay quarterly	Dec 21, 2022

China CITIC Bank	Working Capital	Jun 4, 2021	6		912	2.80	%	Pay in arrear	Dec 2, 2021	Working Capital	Mar 21, 2022	12		1,527	3.00	%	Pay in arrear	Mar 21, 2023

China CITIC Bank	Working Capital	Jun 21, 2021	6		3,805	2.60	%	Pay in arrear	Dec 17, 2021	Working Capital	Mar 23, 2022	12		4,888	3.00	%	Pay in arrear	Mar 23, 2023

China CITIC Bank	Working Capital	Jun 21, 2021	6		1,519	2.60	%	Pay in arrear	Jan 17, 2022
China CITIC Bank ⁽¹⁾										Working Capital	Jun 21, 2021	11		6,474	2.60	%	Pay in arrear	May 17, 2022

China CITIC Bank	Working Capital	Jul 27, 2021	6		1,542	4.35	%	Pay monthly	Jan 27, 2022

Agricultural Bank of China	Working Capital	Mar 18, 2021	12		1,079	4.05	%	Pay monthly	Mar 17, 2022
Hankou Bank										Working Capital	Mar 18, 2022	12		3,091	1.90	%	Pay in arrear	Mar 13, 2023

China CITIC Bank	Working Capital	Mar 22, 2021	12		6,922	3.45	%	Pay in arrear	Mar 18, 2022	Working Capital	Mar 21, 2022	12		5,651	3.00	%	Pay in arrear	Mar 21, 2023

China CITIC Bank	Working Capital	Mar 22, 2021	12		4,166	3.45	%	Pay in arrear	Mar 22, 2022	Working Capital	Jun 21, 2021	12		5,245	2.60	%	Pay in arrear	Jun 21, 2022

China CITIC Bank	Working Capital	Apr 29, 2021	12		1,542	4.35	%	Pay monthly	Apr 29, 2022
China CITIC Bank ⁽¹⁾										Working Capital	Oct 26, 2021	6		62	2.55	%	Pay in arrear	Apr 11, 2022

China CITIC Bank ⁽¹⁾										Working Capital	Nov 16, 2021	6		156	2.70	%	Pay in arrear	Apr 22, 2022

China CITIC Bank ⁽¹⁾										Working Capital	Nov 16, 2021	6		156	2.70	%	Pay in arrear	May 5, 2022

China CITIC Bank ⁽¹⁾										Working Capital	Dec 8, 2021	6		468	2.50	%	Pay in arrear	May 5, 2022

China CITIC Bank ⁽¹⁾										Working Capital	Dec 8, 2021	6		156	2.50	%	Pay in arrear	May 5, 2022

China CITIC Bank	Working Capital	Jun 21, 2021	11		6,337	2.60	%	Pay in arrear	May 17, 2022	Working Capital	Feb 15, 2022	6		469	2.65	%	Pay in arrear	Jun 8, 2022

China CITIC Bank	Working Capital	May 21, 2021	12		1,542	4.35	%	Pay monthly	May 21, 2022	Working Capital	Mar 7, 2022	6		468	2.50	%	Pay in arrear	Jul 21, 2022
													$	48,185
China CITIC Bank	Working Capital	May 28, 2021	12		1,542	4.35	%	Pay monthly	May 28, 2022

China CITIC Bank	Working Capital	Jun 21, 2021	12		5,134	2.60	%	Pay in arrear	Jun 21, 2022

Bank of China	Working Capital	Aug 27, 2021	12		3,084	3.80	%	Pay monthly	Aug 27, 2022

Bank of China	Working Capital	Sep 23, 2021	12		3,084	3.80	%	Pay monthly	Sep 23, 2022
				$	42,210

(1)	These bank loans were repaid in April and May 2022 when they became due.

The Company must use the loans for the purpose described and repay the principal outstanding on the specified date in the table. If it fails to do so, it will be charged additional 30% to 100% penalty interest.

~~The Company has complied with such financial covenants as of September 30, 2021.~~

3730

Table of Contents

The Company had complied with such financial covenants as of March 31, 2022.

Notes Payable

The following table summarizes the contract information of issuing notes payable between the banks and the Company as of ~~September 30, 2021~~March 31, 2022 (figures are in thousands of USD):


			Amount				Amount
			Payable on				Payable on
Purpose	Term (Months)	Due Date	Due Date		Term (Months)	Due Date	Due Date
Working Capital⁽¹⁾	6	Oct. 2021		13,343	6	Apr. 2022		12,310
Working Capital	6	Nov. 2021		11,710
Working Capital⁽¹⁾					6	May. 2022		12,199
Working Capital	6	Dec. 2021		15,539	6	Jun. 2022		18,829
Working Capital	6	Jan. 2022		13,795	6	Jul. 2022		15,896
Working Capital	6	Feb. 2022		14,692	6	Aug.2022		11,035
Working Capital	6	Mar. 2022		13,167	6	Sep. 2022		16,490
Total (See Note 8)				82,246			$	86,759

(1)	The notes payable were repaid in full on their respective due dates.

The Company must use notes payable for the purpose described in the table. If it fails to do so, the banks will no longer issue the notes payable, and it may have an adverse effect on the Company’s liquidity and capital resources. The Company has to deposit sufficient cash on the due date of notes payable for payment to the suppliers. If the bank has advanced payment for the Company, it will be charged an additional 50% penalty interest. The Company complied with such financial covenants as of ~~September 30, 2021.~~March 31, 2022.

Cash Flows

~~(a)Operating Activities~~

(a)	Operating Activities

Net cash used in operating activities for the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022 was ~~$5.9~~$4.3 million, compared ~~with net cash provided in operating activities of $52.7~~to $0.8 million for the same period of ~~2020,~~2021, representing an increase in net cash outflows by ~~$58.6~~$3.5 million, which was mainly due to (1) the ~~increase~~decrease in the cash outflows from movements of accrued expenses and other payables by $2.1 million,(2) the decrease in net income excluding non-cash items by ~~$19.9~~$1.6 million, ~~(2)~~(3) the decrease in cash inflows from movements of accounts and notes receivable by ~~$22.8~~$7.2 million, ~~(3)~~(4) the increase in the cash outflows from movements of accounts and notes payable by ~~$22.0 million, (4) the increase in the cash outflows from movements of inventories by $20.1~~$3.0 million, and (5) a combination of other factors contributing an increase of cash inflows by $6.2 million, including the decrease in the cash outflows from movements of inventory by ~~$13.6 million.~~$4.5 million

~~(b)Investing Activities~~

(b)	Investing Activities

Net cash used in investing activities for the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022 was ~~$2.2~~$45.6 million, as compared to net cash used in investing activities of ~~$33.8~~$5.8 million for the same period of ~~2020,~~2021, representing an increase in net cash ~~inflows~~outflows by ~~$31.6~~$39.8 million, which was mainly due to the net effect of (1) a decrease in payments to acquire property, plant and equipment by ~~$3.5~~$2.2 million, (2) an increase in ~~cash received from proceeds from maturities~~purchase of short-term ~~investment by $18.4~~investments and long-term time deposits of $30.0 million and (3) a combination of other factors contributing an increase of cash ~~inflows~~outflows by ~~$9.7~~$12.0 million, primarily including ~~an increase~~a decrease in ~~purchase~~proceeds from maturities of short-term ~~investment and long-term time deposits~~investments by ~~$3.5~~$8.1 million, and an increase in ~~cash received from long-term~~ investment under the equity method by ~~$9.7~~$4.7 million.

~~(c)Financing Activities~~

(c)	Financing Activities

Net cash used in financing activities for the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022 was ~~$6.0~~$0.7 million, compared to net cash ~~used in~~provided by financing activities of ~~$14.5~~$1.4 million for the same period of ~~2020,~~2021, representing ~~a decrease~~an increase in net cash outflows by ~~$8.5~~$2.1 million, which was mainly due to the net effect of (1) ~~a decrease~~an increase in ~~repayments of~~proceeds from bank loan by ~~$5.7~~$3.5 million, and (2) ~~a combination of other factors contributing~~ an increase in repayment of ~~cash inflows~~bank loans by ~~$2.8~~$5.6 million.

Table of Contents

Off-Balance Sheet Arrangements

~~Table of Contents~~

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

There were no material changes to the disclosure made in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2020~~2021 regarding this matter.

ITEM 4. CONTROLS AND PROCEDURES.

A.	Disclosure Controls and Procedures

The Company’s management, under the supervision and with the participation of its chief executive officer and chief financial officer, Messrs. Wu Qizhou and Li Jie, respectively, evaluated the effectiveness of the Company’s disclosure controls and procedures as of ~~September 30, 2021,~~March 31, 2022, the end of the period covered by this Report. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports, such as this Form 10-Q, that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Based on that evaluation, Messrs. Wu and Li concluded that the Company’s disclosure controls and procedures were effective as of ~~September 30, 2021.~~March 31, 2022.

The Company’s disclosure controls and procedures are designed to provide reasonable, not absolute, assurance that the objectives of its disclosure control system are met. Because of inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within a company have been detected.

B.	Changes in Internal Control Over Financial Reporting

There have been no changes in the Company’s internal control over financial reporting during the three months ended ~~September 30, 2021~~March 31, 2022 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

3932

Table of Contents

PART II. — OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

ITEM 1A. RISK FACTORS.

~~The recent government interference into business activities of U.S. listed Chinese companies may negatively impact our operations.~~

Recently, certain PRC regulatory authorities issued Opinions on Strictly Cracking Down on Illegal Securities Activities, which were available to the public on July 6, 2021, which further emphasized their goal to strengthen the cross-board regulatory collaboration, to improve relevant laws and regulations on data security, cross-border data transmission and confidential information management, and provided that efforts will be made to revise the regulations on strengthening the confidentiality and file management relating to the offering and listing of securities overseas, to implement the responsibility on information security of overseas listed companies, and to strengthen the standardized management of cross-border information provision mechanisms and procedures. However, these opinions were newly issued, and there were no further explanations or detailed rules or regulations with respect to such opinions, and there are still uncertainties regarding the interpretation and implementation of these opinions. China intends to improve regulation of cross-border data flows and security, crack down on illegal activity in the securities market and punish fraudulent securities issuance, market manipulation and insider trading. China will also check sources of funding for securities investment and control leverage ratios. The Cyberspace Administration of China has also opened a cyber security probe into several U.S.-listed tech giants focusing on anti-monopoly, financial technology regulation and more recently, with the passage of the Data Security Law, how companies collect, store, process and transfer data. If the Chinese government’s interference expands, our operations may be negatively impacted in a significant way, although, presently, there is no discernible immediate impact.

~~Table of Contents~~

If the Company becomes directly subject to the recent scrutiny, criticism and negative publicity involving U.S.-listed Chinese companies, we may have to expend significant resources to investigate and resolve the matters. Any unfavorable results from the investigations could harm our business operations, and our reputation.

Recently, U.S. public companies that have substantially all of their operations in China have been subjects of intense scrutiny, criticism and negative publicity by investors, financial commentators and regulatory agencies, such as the SEC. Much of the scrutiny, criticism and negative publicity has centered on financial and accounting irregularities, lack of effective internal control over financial accountings, inadequate corporate governance and ineffective implementation thereof and, in many cases, allegations of fraud. As a result of enhanced scrutiny, criticism and negative publicity, the publicly traded stocks of many U.S. listed Chinese companies have sharply decreased in value and, in some cases, have become virtually worthless or illiquid. Many of these companies are now subject to shareholder lawsuits and SEC enforcement actions and are conducting internal and external investigations into the allegations. It is not clear what effects the sector-wide investigations will have on the Company. If the Company becomes a subject of any unfavorable allegations, whether such allegations are proven to be true or untrue, the Company will have to expend significant resources to investigate such allegations and defend the Company. If such allegations were not proven to be baseless, the Company would be severely hampered and the price of the stock of the Company could decline substantially. If such allegations were proven to be groundless, the investigation might have significantly distracted the attention of the Company’s management.

~~The Company could be delisted if it is unable to timely meet the PCAOB inspection requirements established by the Holding Foreign Companies Accountable Act.~~

On December 18, 2020, the Holding Foreign Companies Accountable Act, or HFCAA, was enacted. In essence, the act requires the SEC to prohibit securities of any foreign companies from being listed on U.S. securities exchanges or traded “over-the-counter” if a company retains a foreign accounting firm that cannot be inspected by the PCAOB for three consecutive years, beginning in 2021. Our independent registered public accounting firm is located in and organized under the laws of the PRC, a jurisdiction where the PCAOB is currently unable to conduct inspections without the approval of the Chinese authorities, and therefore our auditors are not currently inspected by the PCAOB.

On March 24, 2021, the SEC adopted interim final amendments, which will become effective 30 days after publication in the Federal Register, relating to the implementation of certain disclosure and documentation requirements of the HFCAA. The interim final amendments will apply to registrants that the SEC identifies as having filed an annual report with an audit report issued by a registered public accounting firm that is located in a foreign jurisdiction and that the PCAOB has determined it is unable to inspect or investigate completely because of a position taken by an authority in that jurisdiction. Before any registrant will be required to comply with the interim final amendments, the SEC must implement a process for identifying such registrants. As of the date of this annual report, the SEC is seeking public comment on this identification process. Consistent with the HFCAA, the amendments will require any identified registrant to submit documentation to the SEC establishing that the registrant is not owned or controlled by a government entity in that jurisdiction, and will also require, among other things, disclosure in the registrant’s annual report regarding the audit arrangements of, and government influence on, such registrant.

On June 22, 2021, the U.S. Senate passed a bill which, if passed by the U.S. House of Representatives and signed into law, would reduce the number of consecutive non-inspection years required for triggering the prohibitions under the HFCAA from three years to two.

On September 22, 2021, the PCAOB adopted a new rule related to its responsibilities under the HFCAA, which provides a framework for the PCAOB to use when determining, as contemplated under the HFCAA, whether it is unable to inspect or investigate completely registered public accounting firms located in a foreign jurisdiction because of a position taken by one or more authorities in that jurisdiction. The new rule is subject to approval by the SEC. While we understand that there has been dialogue among the China Securities Regulatory Commission, the SEC and the PCAOB regarding the inspection of PCAOB-registered accounting firms in China, there can be no assurance that we will be able to comply with requirements imposed by U.S. regulators.

The SEC may propose additional rules or guidance that could impact us if our auditor is not subject to PCAOB inspection. For example, on August 6, 2020, the President's Working Group on Financial Markets, or the PWG, issued the Report on Protecting United States Investors from Significant Risks from Chinese Companies to the then President of the United States. This report recommended that the SEC implement five recommendations to address companies from jurisdictions that do not provide the PCAOB with sufficient access to fulfil its statutory mandate. Some of the concepts of these recommendations were implemented with the enactment of the HFCAA. However, some of the recommendations were more stringent than the HFCAA. For example, if a company was not subject to PCAOB inspection, the report recommended that the transition period before a company would be delisted would end on January 1, 2022.

~~Table of Contents~~

It is unclear when the SEC will complete its rulemaking, when such rules will become effective and what, if any, of the PWG recommendations will be adopted. The enactment of the HFCAA and the implications of any additional rulemaking efforts to increase U.S. regulatory access to audit information in China could cause investor uncertainty for affected SEC registrants, including us, and the market price of our stock could be materially adversely affected. Additionally, whether the PCAOB will be able to conduct inspections of our auditors in the next three years, or at all, is subject to substantial uncertainty and depends on a number of factors out of our control. If we are unable to meet the PCAOB inspection requirement in time, we could be delisted from the Nasdaq Capital Market and our stock will not be permitted for trading “over-the-counter” either. Such a delisting would substantially impair your ability to sell or purchase our stock when you wish to do so, and the risk and uncertainty associated with delisting would have a negative impact on the price of our stock. Also, such a delisting would significantly affect our ability to raise capital on terms acceptable to us, or at all, which would have a material adverse impact on our business, financial condition and prospects.

~~Except for as set forth above, there~~There have been no material changes from the risk factors previously disclosed in Item 1A of the Company’s ~~2020~~2021 Annual Report on Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

None.

4233

Table of Contents

ITEM 6. EXHIBITS.

INDEX TO EXHIBITS


Exhibit Number		Description

3.1(i)		Certificate of Incorporation (incorporated by reference from the filing on Form 10SB12G File No. 000-33123).

3.1(ii)		Bylaws (incorporated by reference from the Form 10SB12G File No. 000-33123).

10.1		Joint-venture Agreement, dated ~~June 30,~~March 31, 2006, as amended on May 2, 2006, between Great Genesis Holdings Limited and Wuhu Chery Technology Co., Ltd. (incorporated by reference to Exhibit 10.8 to the Company’s Form 10-Q Quarterly Report on May 10, 2006).

10.2		Stock Exchange Agreement dated August 11, 2014 by and among Jingzhou City Jiulong Machinery Electricity Manufacturing Co., Ltd., China Automotive Systems, Inc. and Hubei Henglong Automotive System Group Co., Ltd. (incorporated by reference to Exhibit 10.2 to the Company’s Form 10-Q Quarterly Report on August 13, 2014).

10.3		English translation of Joint Venture Contract, dated as of April 27, 2018, by and between Hubei Henglong Automotive System Group Co., Ltd. and KYB (China) Investment Co., Ltd. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 27, 2018).

31.1		Rule 13a-14(a) Certification*

31.2		Rule 13a-14(a) Certification*

32.1		Section 1350 Certification*

32.2		Section 1350 Certification*

101.INS*		XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH*		XBRL Taxonomy Extension Schema Document

101.CAL*		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*		XBRL Taxonomy Extension Label Linkbase Document

101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document

Exhibit 104*		Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

*filed herewith

4334

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.


	CHINA AUTOMOTIVE SYSTEMS, INC.
	(Registrant)

Date: ~~November 12, 2021~~May 23, 2022	By:	/ s/ Qizhou Wu
		Qizhou Wu
		President and Chief Executive Officer

Date: ~~November 12, 2021~~May 23, 2022	By:	/s/ Jie Li
		Jie Li
		Chief Financial Officer

4435


Issuance Date	Expected volatility		Risk-free rate		Expected term (years)	Dividend yield
February 3, 2021	76.91	%	0.46	%	5	0.00	%


				Weighted-
		Weighted-		Average
		Average		Contractual
	Shares	Exercise Price		Term (years)
Outstanding - January 1, 2020	30,000	$	4.99	5
Expired	(7,500)		4.58	5
Outstanding - December 31, 2020	22,500	$	4.79	5
Granted	22,500		6.26	5
Outstanding - September 30, 2021	45,000	$	5.52	5


	Outstanding Stock	Weighted Average	Weighted Average	Number of Stock
Range of Exercise Prices	Options	Remaining Life	Exercise Price	Options Exercisable
$2.37 - $6.95	45,000	1.89	5.52	45,000


	Net Product Sales				Net (Loss)/Income
	Nine Months Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
Henglong	$	138,151	$	100,651	$	(877)	$	(298)
Jiulong		76,248		64,948		650		(53)
Shenyang		11,988		9,860		186		330
Wuhu		17,598		8,742		117		223
Hubei Henglong		98,338		76,565		1,893		5,391
Henglong KYB		53,961		32,987		(72)		(3,484)
Other Entities		67,247		39,054		5,470		(2,370)
Total Segments		463,531		332,807		7,367		(261)
Corporate		0		0		(1,221)		(1,766)
Eliminations		(104,355)		(61,651)		(255)		(1,328)
Total	$	359,176	$	271,156	$	5,891	$	(3,355)

Three Months Ended March 31,

Equity interest purchase from related parties